© 2000-2024 QIAGEN. All rights reserved.

Ingenuity Canonical Pathways	 -log(p-value)	Ratio	z-score	Molecules	
Eukaryotic Translation Initiation	2.6E01	3.77E-01	-6.782	EIF2B4,EIF2S2,EIF3E,EIF3F,EIF3H,EIF3I,EIF3K,EIF3L,EIF3M,EIF4A1,EIF4E,EIF4H,FAU,RPL11,RPL13,RPL18,RPL19,RPL21,RPL22,RPL27A,RPL28,RPL3,RPL30,RPL35A,RPL37,RPL37A,RPL38,RPL39,RPL41,RPL6,RPL7,RPL9,RPLP0,RPS10,RPS13,RPS15A,RPS20,RPS21,RPS24,RPS26,RPS28,RPS29,RPS4Y1,RPS5,RPS7,RPS9	
SRP-dependent cotranslational protein targeting to membrane	2.31E01	3.65E-01	-6.481	DDOST,FAU,RPL11,RPL13,RPL18,RPL19,RPL21,RPL22,RPL27A,RPL28,RPL3,RPL30,RPL35A,RPL37,RPL37A,RPL38,RPL39,RPL41,RPL6,RPL7,RPL9,RPLP0,RPS10,RPS13,RPS15A,RPS20,RPS21,RPS24,RPS26,RPS28,RPS29,RPS4Y1,RPS5,RPS7,RPS9,SEC11A,SEC61G,SPCS1,SPCS2,SRP14,SRP9,SSR2	
Mitochondrial translation	2.25E01	3.96E-01	-6.164	AURKAIP1,CHCHD1,GADD45GIP1,MRPL15,MRPL18,MRPL2,MRPL20,MRPL22,MRPL24,MRPL27,MRPL3,MRPL30,MRPL32,MRPL35,MRPL39,MRPL4,MRPL40,MRPL41,MRPL43,MRPL48,MRPL50,MRPL53,MRPL55,MRPL58,MRPL9,MRPS14,MRPS15,MRPS16,MRPS17,MRPS18A,MRPS18C,MRPS21,MRPS23,MRPS26,MRPS31,MRPS34,MRPS7,MTRF1L	
EIF2 Signaling	2.23E01	2.52E-01	-5.014	ACTB,ATF3,CDK11A,EIF2B4,EIF2S2,EIF3E,EIF3F,EIF3H,EIF3I,EIF3K,EIF3L,EIF3M,EIF4A1,EIF4A3,EIF4E,FAU,HRAS,MAPK3,PPP1R15A,RAP1A,RASD1,RPL11,RPL13,RPL18,RPL19,RPL21,RPL22,Rpl22l1,RPL27A,RPL28,RPL3,RPL30,Rpl34 (includes others),RPL35A,Rpl36,RPL37,RPL37A,RPL38,RPL39,RPL41,RPL6,RPL7,RPL9,RPLP0,RPS10,RPS13,RPS15A,RPS20,RPS21,RPS24,RPS26,RPS28,RPS29,RPS4Y1,RPS5,RPS7,RPS9,RRAS	
Eukaryotic Translation Termination	1.97E01	3.72E-01	-5.916	FAU,RPL11,RPL13,RPL18,RPL19,RPL21,RPL22,RPL27A,RPL28,RPL3,RPL30,RPL35A,RPL37,RPL37A,RPL38,RPL39,RPL41,RPL6,RPL7,RPL9,RPLP0,RPS10,RPS13,RPS15A,RPS20,RPS21,RPS24,RPS26,RPS28,RPS29,RPS4Y1,RPS5,RPS7,RPS9,TRMT112	
Eukaryotic Translation Elongation	1.95E01	3.68E-01	-5.916	EEF1D,FAU,RPL11,RPL13,RPL18,RPL19,RPL21,RPL22,RPL27A,RPL28,RPL3,RPL30,RPL35A,RPL37,RPL37A,RPL38,RPL39,RPL41,RPL6,RPL7,RPL9,RPLP0,RPS10,RPS13,RPS15A,RPS20,RPS21,RPS24,RPS26,RPS28,RPS29,RPS4Y1,RPS5,RPS7,RPS9	
Response of EIF2AK4 (GCN2) to amino acid deficiency	1.92E01	3.5E-01	-6.000	ATF3,EIF2S2,FAU,RPL11,RPL13,RPL18,RPL19,RPL21,RPL22,RPL27A,RPL28,RPL3,RPL30,RPL35A,RPL37,RPL37A,RPL38,RPL39,RPL41,RPL6,RPL7,RPL9,RPLP0,RPS10,RPS13,RPS15A,RPS20,RPS21,RPS24,RPS26,RPS28,RPS29,RPS4Y1,RPS5,RPS7,RPS9	
Nonsense-Mediated Decay (NMD)	1.8E01	3.16E-01	-6.083	EIF4A3,FAU,NCBP2,RBM8A,RPL11,RPL13,RPL18,RPL19,RPL21,RPL22,RPL27A,RPL28,RPL3,RPL30,RPL35A,RPL37,RPL37A,RPL38,RPL39,RPL41,RPL6,RPL7,RPL9,RPLP0,RPS10,RPS13,RPS15A,RPS20,RPS21,RPS24,RPS26,RPS28,RPS29,RPS4Y1,RPS5,RPS7,RPS9	
Selenoamino acid metabolism	1.67E01	3.18E-01	-5.831	FAU,RPL11,RPL13,RPL18,RPL19,RPL21,RPL22,RPL27A,RPL28,RPL3,RPL30,RPL35A,RPL37,RPL37A,RPL38,RPL39,RPL41,RPL6,RPL7,RPL9,RPLP0,RPS10,RPS13,RPS15A,RPS20,RPS21,RPS24,RPS26,RPS28,RPS29,RPS4Y1,RPS5,RPS7,RPS9	
Processing of Capped Intron-Containing Pre-mRNA	1.54E01	1.92E-01	-7.416	BCAS2,C9orf78,CCDC12,DDX39B,DDX5,EIF4A3,EIF4E,FAM32A,GLE1,HNRNPF,HNRNPK,HSPA8,LENG1,LSM3,LSM5,LSM8,MFAP1,NCBP2,NXT1,PCBP1,PDCD7,PHF5A,POLR2C,POLR2D,POLR2E,POLR2I,POLR2K,PPWD1,PRPF38A,PUF60,RBM22,RBM42,RBM7,RBM8A,SAP18,SEC13,SF3B4,SF3B6,SMU1,SNRNP27,SNRNP40,SNRNP48,SNRPB,SNRPB2,SRSF11,SRSF2,SRSF3,SRSF7,SRSF9,SYF2,THOC1,THOC7,TRA2B,UBL5,ZMAT5	
Major pathway of rRNA processing in the nucleolus and cytosol	1.45E01	2.26E-01	-6.481	C1D,CSNK1E,EMG1,EXOSC1,EXOSC8,FAU,FCF1,RPL11,RPL13,RPL18,RPL19,RPL21,RPL22,RPL27A,RPL28,RPL3,RPL30,RPL35A,RPL37,RPL37A,RPL38,RPL39,RPL41,RPL6,RPL7,RPL9,RPLP0,RPS10,RPS13,RPS15A,RPS20,RPS21,RPS24,RPS26,RPS28,RPS29,RPS4Y1,RPS5,RPS7,RPS9,RRP7A,UTP11	
HSP90 chaperone cycle for steroid hormone receptors in the presence of ligand	1.13E01	3.64E-01	-4.472	ACTR10,CAPZA2,DCTN2,DCTN3,DCTN4,DCTN5,DCTN6,DNAJA1,DNAJA2,DNAJA4,DNAJB1,DYNLL1,FKBP4,HSPA1A/HSPA1B,HSPA8,STIP1,TUBA1A,TUBA1B,TUBB2A,TUBB4B	
mTOR Signaling	1.1E01	1.87E-01	-2.138	AKT1S1,Cdc42,EIF3E,EIF3F,EIF3H,EIF3I,EIF3K,EIF3L,EIF3M,EIF4A1,EIF4A3,EIF4E,FAU,HRAS,MAPK3,PPP2CB,PRKAB1,PRKAG1,PRR5L,RAP1A,RASD1,RHEB,RHOA,RHOB,RHOC,RHOG,RPS10,RPS13,RPS15A,RPS20,RPS21,RPS24,RPS26,RPS28,RPS29,RPS4Y1,RPS5,RPS7,RPS9,RRAS	
COPI-mediated anterograde transport	9.7E00	2.45E-01	-5.000	ACTR10,ARF1,ARF4,ARF5,ARFGAP2,BET1,BET1L,CAPZA2,COG8,COPZ1,DCTN2,DCTN3,DCTN4,DCTN5,DCTN6,DYNLL1,KDELR1,KDELR2,NAPA,TMED2,TMED9,TUBA1A,TUBA1B,TUBB2A,TUBB4B	
Sirtuin Signaling Pathway	9.43E00	1.55E-01	-0.707	ATG101,ATG5,CYC1,GABARAP,GABARAPL2,GADD45G,H3-3A/H3-3B,JUN,LDHA,MAP1LC3A,MAP1LC3B,MAPK3,MLYCD,NDRG1,NDUFA1,NDUFA3,NDUFA6,NDUFA7,NDUFB10,NDUFB11,NDUFS2,NDUFS3,NFE2L2,NR1H2,PGAM1,POLR1D,PPID,SDHB,SDHD,SIRT2,SIRT7,SLC2A1,TIMM17A,TOMM20,TOMM22,TOMM6,TOMM7,TUBA1A,TUBA1B,UCP2,UQCRFS1,VDAC1,VDAC2,VDAC3,ZIC2	
Huntington's Disease Signaling	9.26E00	1.55E-01	-2.530	AP2A2,BET1L,CASP6,CLTA,CREB3,CTSD,DNAJB1,GNA11,GNB2,GNG11,GNG5,HRAS,HSPA1A/HSPA1B,Hspa1b,HSPA8,JUN,MAPK3,NAPA,POLR2C,POLR2D,POLR2E,POLR2I,POLR2K,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,SDHB,SDHD,SEM1,SGK1,Ubb,UBC,UBE2S,VAMP3,VTI1B	
Protein Ubiquitination Pathway	8.77E00	1.54E-01	NaN	ANAPC10,ANAPC11,DNAJA1,DNAJB1,DNAJB9,DNAJC30,ELOC,HLA-A,HLA-E,HSPA12B,HSPA1A/HSPA1B,HSPA8,HSPB1,MED20,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,STUB1,TAP2,Ubb,UBC,UBE2A,UBE2B,UBE2D3,UBE2G2,UBE2I,UBE2L6,UBE2M,UBE2N,UBE2S,UBE2V1,UBE2V2,USP18	
Regulation of eIF4 and p70S6K Signaling	8.73E00	1.79E-01	-1.342	EIF2B4,EIF2S2,EIF3E,EIF3F,EIF3H,EIF3I,EIF3K,EIF3L,EIF3M,EIF4A1,EIF4A3,EIF4E,FAU,HRAS,MAPK3,PAIP2,PPP2CB,RAP1A,RASD1,RPS10,RPS13,RPS15A,RPS20,RPS21,RPS24,RPS26,RPS28,RPS29,RPS4Y1,RPS5,RPS7,RPS9,RRAS	
PTEN Regulation	8.52E00	1.93E-01	-3.800	CSNK2B,EZH2,JUN,LAMTOR1,MAF1,MAPK3,MBD3,MKRN1,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,RBBP4,RHEB,RNF2,RRAGA,RRAGC,SEM1,STUB1,UBC,VAPA	
Neutrophil degranulation	8.27E00	1.24E-01	-7.681	ACAA1,ACTR10,ADGRE5,ALAD,ALDOA,AP1M1,AP2A2,ARL8A,ATP6V0C,BRI3,CCT8,CEACAM1,CNN2,COMMD3,CSNK2B,CST3,CTSC,CTSD,CTSH,DDOST,DNASE1L1,DYNLL1,FTL,GGH,HSPA1A/HSPA1B,HSPA8,IST1,JUP,LAMP1,LAMTOR1,NDUFC2,ORMDL3,OSTF1,PGAM1,PGRMC1,PNP,PRDX4,PRDX6,PSMA5,PSMC2,PSMC3,PSMD13,PSMD6,RAB18,RAB24,RAP1A,RHOA,RHOG,RNASET2,SERPINB6,SRP14,TMEM179B,TRAPPC1,TTR,TUBB,TUBB4B,VAMP8,VAPA,YPEL5	
Neddylation	8.05E00	1.54E-01	-6.164	BTBD1,CDKN1A,COMMD2,COMMD3,COMMD4,COPS4,COPS5,COPS8,DCUN1D5,ELOC,FBXL12,FBXO22,FBXO6,GPS1,NAE1,NFE2L2,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,RNF7,SEM1,SOCS2,SPSB3,SQSTM1,UBC,UBE2D3,UBE2M,WSB1,ZBTB16	
Class I MHC mediated antigen processing and presentation	7.7E00	1.31E-01	-7.000	ANAPC10,ANAPC11,ANAPC13,BTBD1,CTSV,ELOC,FBXL12,FBXO22,FBXO6,HLA-A,HLA-E,MKRN1,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,RCHY1,RNF126,RNF7,SAR1B,SEC13,SEM1,SIAH1,STUB1,TAP2,UBA5,UBC,UBE2A,UBE2B,UBE2D3,UBE2G2,UBE2L6,UBE2M,UBE2N,UBE2S,UBE2V1,UBE2V2,VAMP3,VAMP8,WSB1,ZBTB16	
Phagosome Maturation	7.61E00	1.77E-01	NaN	ATP6V0B,ATP6V0C,ATP6V0D1,ATP6V0E1,ATP6V1F,ATP6V1G1,BET1L,CTSC,CTSD,CTSF,CTSH,CTSV,DCTN4,Dync1i2,DYNLL1,DYNLRB1,HLA-A,HLA-E,LAMP1,NAPA,PRDX6,RAB5A,TUBA1A,TUBA1B,TUBB,TUBB2A,TUBB4B,VAMP3,VTI1B	
Mitophagy	7.58E00	4E-01	-3.464	ATG5,CSNK2B,MAP1LC3A,MAP1LC3B,PINK1,SQSTM1,TOMM20,TOMM22,TOMM6,TOMM7,UBC,VDAC1	
BAG2 Signaling Pathway	7.57E00	2.35E-01	-1.134	CDKN1A,HSPA1A/HSPA1B,Hspa1b,HSPA8,MAPK3,PINK1,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,SEM1,STUB1	
Mitotic G2-G2/M phases	7.3E00	1.61E-01	-5.657	CDK11A,CDKN1A,CEP57,CETN2,CSNK1E,DCTN2,DCTN3,DYNLL1,MZT1,PPP2CB,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,RBBP4,SEM1,SSNA1,TUBA1A,TUBA1B,TUBB,TUBB2A,TUBB4B,UBC,YWHAE	
Protein folding	7.16E00	2.14E-01	-4.583	ACTB,CCT4,CCT5,CCT8,CSNK2B,FBXO6,GNA11,GNB2,GNG11,GNG5,PFDN1,PFDN2,PFDN5,TBCA,TBCB,TBCC,TUBA1A,TUBA1B,TUBB2A,TUBB4B,VBP1	
Metabolism of polyamines	7.11E00	2.71E-01	-4.000	OAZ1,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,SAT1,SEM1,SMOX	
Intra-Golgi and retrograde Golgi-to-ER traffic	7.1E00	1.58E-01	-5.657	ACTR10,ARF1,ARF4,ARF5,ARFGAP2,ARL1,BET1L,CAPZA2,COG8,COPZ1,CYTH2,DCTN2,DCTN3,DCTN4,DCTN5,DCTN6,DYNLL1,KDELR1,KDELR2,NAA35,NAPA,PLIN3,RAB18,RAB9A,SYS1,TMED2,TMED9,TUBA1A,TUBA1B,TUBB2A,TUBB4B,VAMP3	
Mitotic Metaphase and Anaphase	7.06E00	1.49E-01	-5.916	ANAPC10,ANAPC11,ANAPC16,BUB3,CHMP2B,CHMP6,DYNLL1,IST1,LEMD2,NDEL1,NUDC,PPP2CB,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,SEC13,SEM1,SIRT2,SUMO1,TUBA1A,TUBA1B,TUBB2A,TUBB4B,UBC,UBE2I,UBE2S	
Cellular response to hypoxia	7.02E00	2.4E-01	-4.243	EGLN2,ELOC,HIGD1A,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,SEM1,UBC,UBE2D3	
Hypoxia Signaling in the Cardiovascular System	6.93E00	2.37E-01	-2.236	COPS5,CREB3,EDN1,JUN,LDHA,NFKBIA,SUMO1,UBE2A,UBE2B,UBE2D3,UBE2G2,UBE2I,UBE2L6,UBE2M,UBE2N,UBE2S,UBE2V1,UBE2V2	
Ferroptosis Signaling Pathway	6.71E00	1.83E-01	-2.041	ARF1,ARF4,ARF5,ARF6,CDKN1A,DPP4,FTL,GPX4,HRAS,HSPB1,MAPK3,NCOA4,NFE2L2,PRKAB1,PRKAG1,RAP1A,RASD1,RRAS,SAT1,SLC39A8,SLC3A2,SQSTM1,TFRC,VDAC2	
Regulation of mitotic cell cycle	6.59E00	2.16E-01	-4.359	ANAPC10,ANAPC11,ANAPC16,BUB3,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,SEM1,UBC,UBE2S	
Inhibition of ARE-Mediated mRNA Degradation Pathway	6.53E00	1.66E-01	-0.535	CNOT3,CNOT8,EXOSC1,EXOSC8,MAPK3,POMC,PPP2CB,PRKAG1,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,SEM1,TNFSF12,TNFSF13,YWHAE,YWHAH,YWHAQ,ZFP36	
FAT10 Signaling Pathway	6.51E00	2.63E-01	NaN	MAP1LC3B,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,SEM1,SQSTM1	
MHC class II antigen presentation	6.43E00	1.83E-01	-4.796	ACTR10,AP1M1,AP2A2,ARF1,CAPZA2,CLTA,CTSC,CTSD,CTSF,CTSH,CTSV,DCTN2,DCTN3,DCTN4,DCTN5,DCTN6,DYNLL1,SAR1B,SEC13,TUBA1A,TUBA1B,TUBB2A,TUBB4B	
KEAP1-NFE2L2 pathway	6.35E00	2.09E-01	-4.359	CDKN1A,CSNK2B,MAP1LC3B,NFE2L2,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,SEM1,SQSTM1,UBC	
CLEAR Signaling Pathway	6.34E00	1.33E-01	0.973	AKT1S1,ATP6V0B,ATP6V0C,ATP6V0D1,ATP6V0E1,ATP6V1F,ATP6V1G1,BLOC1S1,BNIP3,CASTOR1,CREB3,CTSD,CTSF,GABARAP,GLMP,GSK3A,HRAS,LAMP1,LAMTOR1,MAPK3,NRBF2,PDGFB,PINK1,PIP4P1,PPP2CB,PRKAB1,PRKAG1,RAP1A,RASD1,RHEB,RRAGA,RRAGC,RRAS,SEC13,STUB1,YWHAE,YWHAH,YWHAQ	
Electron transport, ATP synthesis, and heat production by uncoupling proteins	6.3E00	1.8E-01	-4.796	COQ10B,COX19,COX5A,COX7A2L,CYC1,NDUFA1,NDUFA3,NDUFA6,NDUFA7,NDUFAF3,NDUFAF4,NDUFAF7,NDUFB10,NDUFB11,NDUFC2,NDUFS2,NDUFS3,SDHB,SDHD,SURF1,UCP2,UQCR11,UQCRFS1	
RNA Polymerase II Transcription	6.21E00	1.68E-01	-5.000	CDK9,DDX39B,EIF4A3,ELOC,GTF2A2,GTF2B,NCBP2,NELFE,POLR2C,POLR2D,POLR2E,POLR2I,POLR2K,RBM8A,SNRPB,SRSF11,SRSF2,SRSF3,SRSF7,SRSF9,SUPT4H1,TAF11,TAF7,THOC1,THOC7	
NIK-->noncanonical NF-kB signaling	6.2E00	2.5E-01	-3.873	PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,SEM1,UBC,UBE2M	
TNFR2 non-canonical NF-kB pathway	6.18E00	2.35E-01	-4.000	CD40,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,SEM1,TNFSF12,UBC	
Regulation of Apoptosis	6.14E00	2.64E-01	-3.742	PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,SEM1,UBC	
Mitotic G1 phase and G1/S transition	6.12E00	1.76E-01	-4.472	CABLES1,CDKN1A,CDKN1B,CDKN2B,CDKN2D,MAX,ORC6,PPP2CB,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,RBBP4,SEM1,UBC	
Nucleotide Excision Repair	5.9E00	1.96E-01	-4.359	CETN2,COPS4,COPS5,COPS8,GPS1,POLD4,POLR2C,POLR2D,POLR2E,POLR2I,POLR2K,RAD23A,RPA3,SUMO1,SUMO2,UBC,UBE2I,UBE2N,UBE2V2	
Mitochondrial protein import	5.81E00	2.34E-01	-3.873	CHCHD7,COX17,COX19,CYC1,GRPEL1,IDH3G,MTX1,PMPCB,TIMM10B,TIMM17A,TOMM20,TOMM22,TOMM6,TOMM7,VDAC1	
Estrogen Receptor Signaling	5.77E00	1.15E-01	-4.218	BAD,CCNC,CDK8,CDKN1A,CFL1,CFL2,CREB3,CYC1,DDX5,EIF2B4,EIF4E,FOS,GNA11,GNAS,GNB2,GNG11,GNG5,GSK3A,HES1,HRAS,JUN,MAPK3,MED10,MED20,MED21,MED31,MED4,MYL11,MYL12A,MYL12B,NDUFA3,NDUFA6,NDUFA7,NDUFB10,NDUFB11,NDUFS2,NDUFS3,NOTUM,PRKAB1,PRKAG1,RAP1A,RASD1,RHOA,RRAS,SDHB,SDHD,UQCRFS1	
ESR-mediated signaling	5.74E00	1.78E-01	-4.583	CDK9,CTSD,CXCL12,DDX5,FKBP4,FOS,FOSB,GTF2A2,JUN,JUND,MAPK3,POLR2C,POLR2D,POLR2E,POLR2I,POLR2K,PPID,PPP5C,PRMT1,USF1,USF2	
Macroautophagy	5.72E00	2.31E-01	-3.873	ATG101,ATG5,CHMP2B,CHMP6,DYNLL1,GABARAP,GABARAPL2,LAMTOR1,MAP1LC3A,MAP1LC3B,PRKAB1,PRKAG1,RHEB,RRAGA,RRAGC	
Hedgehog ligand biogenesis	5.72E00	2.31E-01	-3.873	NOTUM,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,SEM1,UBC	
S Phase	5.69E00	1.9E-01	-3.900	CABLES1,CDKN1A,CDKN1B,MAX,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,RBBP4,SEM1,UBC	
Synthesis of DNA	5.68E00	1.76E-01	-4.583	ANAPC10,ANAPC11,ANAPC16,ORC6,POLD4,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,RPA3,SEM1,UBC,UBE2S	
Degradation of beta-catenin by the destruction complex	5.62E00	1.96E-01	-3.300	PPP2CB,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,SEM1,TCF3,Tcf7,TLE5,UBC	
Microautophagy Signaling Pathway	5.62E00	1.56E-01	-4.899	CHMP5,CHMP6,HSPA8,MAP1LC3A,MAP1LC3B,PRKAB1,PRKAG1,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,RETREG1,SEC13,SQSTM1,TOMM20,VAMP8,VTA1	
Mitochondrial Dysfunction	5.51E00	1.19E-01	3.904	ATP1A2,BAD,Calm1 (includes others),COX17,COX5A,Cox6c,COX7A2L,CREB3,CYC1,GPX1,GPX4,GSTK1,GSTM2,GSTT2/GSTT2B,NDUFA1,NDUFA3,NDUFA6,NDUFA7,NDUFB10,NDUFB11,NDUFS2,NDUFS3,NFE2L2,PDHB,PINK1,PRDX6,PRKAB1,PRKAG1,PSENEN,SDHB,SDHD,SURF1,TOMM20,TOMM22,TOMM7,UCP2,UQCR11,UQCRFS1,VDAC1,VDAC2,VDAC3	
DNA Replication Pre-Initiation	5.43E00	1.83E-01	-4.359	ANAPC10,ANAPC11,ANAPC16,ORC6,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,SEM1,UBC,UBE2S	
14-3-3-mediated Signaling	5.21E00	1.65E-01	-1.807	AKT1S1,BAD,CDKN1B,FOS,GSK3A,HRAS,JUN,MAPK3,NOTUM,RAP1A,RASD1,RRAS,TUBA1A,TUBA1B,TUBB,TUBB2A,TUBB4B,VIM,YWHAE,YWHAH,YWHAQ	
NRF2-mediated Oxidative Stress Response	5.12E00	1.31E-01	-3.638	ACTB,ACTG1,AKR1A1,CLPP,Cyp2d22,DNAJA1,DNAJA2,DNAJA4,DNAJB1,DNAJB9,ENC1,FOS,FTL,GCLM,GSTK1,GSTM2,GSTM5,GSTT2/GSTT2B,HERPUD1,HRAS,JUN,JUNB,JUND,MAPK3,NFE2L2,PPIB,RAP1A,RASD1,RRAS,SQSTM1,STIP1	
Regulation of RUNX2 expression and activity	5.06E00	2.05E-01	-3.873	PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,SEM1,STUB1,UBC	
Deubiquitination	5.02E00	1.25E-01	-5.745	ACTB,ACTR8,ADRB2,FKBP8,INO80B,INO80E,MAT2B,MCRS1,NFKBIA,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,RAD23A,RCE1,RHOA,SEM1,SNX3,TADA3,TOMM20,UBC,USP18,VDAC1,VDAC2,VDAC3	
MAPK6/MAPK4 signaling	4.99E00	1.85E-01	NaN	DNAJB1,HSPB1,JUN,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,SEM1,UBC	
Signaling by NOTCH4	4.98E00	1.93E-01	-4.000	HES1,PSENEN,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,SEM1,UBC	
Iron uptake and transport	4.89E00	2.24E-01	-3.606	ABCG2,ALAD,ATP6V0B,ATP6V0C,ATP6V0D1,ATP6V0E1,ATP6V1F,ATP6V1G1,FTL,GLRX3,SLC40A1,TFRC,UBC	
Hedgehog 'off' state	4.89E00	1.68E-01	-3.742	GNAS,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,SEM1,TUBA1A,TUBA1B,TUBB2A,TUBB4B,UBC	
Transcriptional regulation by RUNX3	4.74E00	1.77E-01	-4.123	CCN2,CDKN1A,HES1,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,SEM1,UBC	
Cell Cycle Checkpoints	4.72E00	1.21E-01	-5.745	ANAPC10,ANAPC11,ANAPC16,BUB3,CDKN1A,CDKN1B,DYNLL1,NDEL1,NUDC,ORC6,PPP2CB,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,RPA3,SEC13,SEM1,UBC,UBE2N,UBE2S,UBE2V2,YWHAE,YWHAH,YWHAQ	
Translocation of SLC2A4 (GLUT4) to the plasma membrane	4.55E00	1.97E-01	-3.742	ACTB,ACTG1,ASPSCR1,EXOC7,PRKAB1,PRKAG1,RAB4A,TUBA1A,TUBA1B,TUBB2A,TUBB4B,YWHAE,YWHAH,YWHAQ	
Transcriptional regulation by RUNX1	4.49E00	1.45E-01	-4.690	CLDN5,CSNK2B,CTSV,LMO2,OCLN,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,RNF2,SEM1,SMARCB1,TCF3,UBC	
ABC-family proteins mediated transport	4.44E00	1.68E-01	-4.123	ABCG1,EIF2S2,PEX3,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,SEM1,UBC	
E3 ubiquitin ligases ubiquitinate target proteins	4.44E00	2.18E-01	-3.464	BCL10,HLA-A,PEX13,PEX2,RNF181,RRAGA,UBC,UBE2A,UBE2B,UBE2D3,UBE2N,UBE2V2	
Amino acids regulate mTORC1	4.44E00	2.18E-01	-3.464	ATP6V0B,ATP6V0C,ATP6V0D1,ATP6V0E1,ATP6V1F,ATP6V1G1,CASTOR1,LAMTOR1,RHEB,RRAGA,RRAGC,SEC13	
Oxidative Phosphorylation	4.39E00	1.61E-01	-4.243	COX17,COX5A,Cox6c,COX7A2L,CYC1,NDUFA1,NDUFA3,NDUFA6,NDUFA7,NDUFB10,NDUFB11,NDUFS2,NDUFS3,SDHB,SDHD,SURF1,UQCR11,UQCRFS1	
C-type lectin receptors (CLRs)	4.32E00	1.45E-01	-4.472	BCL10,HRAS,ICAM2,NFKBIA,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,SEM1,UBC,UBE2M,UBE2N,UBE2V1	
TCR signaling	4.21E00	1.51E-01	-4.359	BCL10,NFKBIA,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,SEM1,UBC,UBE2N,UBE2V1,VASP	
Germ Cell-Sertoli Cell Junction Signaling	4.19E00	1.35E-01	NaN	ACTB,ACTG1,Cdc42,CFL1,CFL2,HRAS,ILK,JUP,MAP3K8,MAPK3,RAP1A,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,TUBA1A,TUBA1B,TUBB,TUBB2A,TUBB4B,ZYX	
Signaling by ROBO receptors	4.18E00	1.55E-01	-4.243	CXCL12,ELOC,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,RHOA,SEM1,UBC,VASP	
Autophagy	4.16E00	1.24E-01	-3.530	AKT1S1,ATG101,ATG5,BAD,BNIP3,Calm1 (includes others),CDKN1B,CREB3,DAPK3,FOS,GABARAP,GABARAPL2,GSK3A,JUN,LAMP1,MAP1LC3A,MAP1LC3B,MAPK3,NRBF2,PDGFB,PPP2CB,PRKAB1,PRKAG1,SLC3A2,SLC7A5,SQSTM1,VAMP8	
Remodeling of Epithelial Adherens Junctions	4.12E00	1.91E-01	-2.236	ACTB,ACTG1,ARF6,ARPC1A,ARPC4,ARPC5L,RAB5A,TUBA1A,TUBA1B,TUBB,TUBB2A,TUBB4B,ZYX	
Cellular response to heat stress	4.11E00	1.65E-01	-3.742	AKT1S1,BAG5,DNAJB1,FKBP4,HIKESHI,HSPA12B,HSPA1A/HSPA1B,HSPA8,HSPB1,MAPK3,MRPL18,RPA3,RPS19BP1,SEC13,ST13,YWHAE	
Interleukin-1 family signaling	4.07E00	1.47E-01	-4.359	MAP3K8,NFKBIA,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,SEM1,SQSTM1,UBC,UBE2N,UBE2V1	
Integrin Signaling	3.93E00	1.23E-01	-2.294	ACTB,ACTG1,ARF1,ARF4,ARF5,ARF6,ARPC1A,ARPC4,ARPC5L,Cdc42,HRAS,ILK,ILKAP,MAPK3,MYL12A,MYL12B,PDGFB,RAP1A,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,VASP,ZYX	
NER (Nucleotide Excision Repair, Enhanced Pathway)	3.89E00	1.65E-01	-1.387	CETN2,COPS4,COPS5,COPS8,GPS1,POLD4,POLR2C,POLR2D,POLR2E,POLR2I,POLR2K,RBBP4,RPA3,UBE2I,UBE2N	
COPII-mediated vesicle transport	3.85E00	1.81E-01	-3.606	BET1,CNIH1,CTSC,LMAN2L,NAPA,SAR1B,SEC13,TMED2,TRAPPC1,TRAPPC2,TRAPPC3,TRAPPC4,TRAPPC5	
Androgen Signaling	3.79E00	1.3E-01	-2.449	Calm1 (includes others),DNAJB1,GNA11,GNAS,GNB2,GNG11,GNG5,GTF2A2,GTF2B,H3-3A/H3-3B,JUN,MAPK3,NCOA4,POLR2C,POLR2D,POLR2E,POLR2I,POLR2K,PRKAG1,TAF11,TAF7,TGFB1I1	
RNA polymerase II transcribes snRNA genes	3.77E00	1.69E-01	-3.742	CDK9,GTF2A2,GTF2B,NABP2,NCBP2,PHAX,POLR2C,POLR2D,POLR2E,POLR2I,POLR2K,SNAPC5,SUPT4H1,TAF11	
Epithelial Adherens Junction Signaling	3.77E00	1.33E-01	-1.091	ARPC1A,ARPC4,ARPC5L,BAIAP2,CFL1,CFL2,HRAS,MYL12A,MYL12B,PPP2CB,PRKAB1,PRKAG1,RAP1A,RASD1,RHOA,RRAS,TCF3,Tcf7,YWHAE,YWHAH,YWHAQ	
trans-Golgi Network Vesicle Budding	3.73E00	1.76E-01	-3.606	AP1M1,ARF1,BLOC1S1,BLOC1S2,BLOC1S4,CLTA,FTL,HSPA8,NAPA,SNAPIN,TFRC,VAMP7,VAMP8	
IGF-1 Signaling	3.69E00	1.52E-01	-1.897	BAD,CCN1,CCN2,CSNK2B,FOS,HRAS,JUN,MAPK3,PRKAG1,RAP1A,RASD1,RRAS,SOCS2,YWHAE,YWHAH,YWHAQ	
ROBO SLIT Signaling Pathway	3.67E00	1.42E-01	0.943	ARF1,ARF4,ARF5,ARF6,ARPC1A,ARPC4,ARPC5L,CABLES1,CDKN1A,FOS,HES1,JUN,MYL12A,MYL12B,NDFIP1,PRDM16,PRKAG1,RHOA	
NGF-stimulated transcription	3.66E00	2.31E-01	-2.828	FOS,FOSB,ID1,ID2,ID3,JUNB,JUND,LYL1,SGK1	
Hedgehog 'on' state	3.61E00	1.63E-01	-3.742	PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,SEM1,UBC	
Polyamine Regulation in Colon Cancer	3.47E00	1.86E-01	-1.508	AKT1S1,CSNK2B,EIF5A,FOS,JUN,MAPK3,OAZ1,RHOA,SAT1,SLC3A2,SMOX	
HER-2 Signaling in Breast Cancer	3.45E00	1.15E-01	0.816	AKT1S1,ARF1,ARF4,ARF5,ARF6,BAD,CASP6,CDKN1A,CDKN1B,COX17,COX5A,Cox6c,COX7A2L,FOS,GLE1,GSK3A,HRAS,JUN,MAPK3,NFKBIA,RAP1A,RASD1,RHEB,RRAS,SEC13,SURF1	
Protein Kinase A Signaling	3.42E00	9.73E-02	-0.898	AKAP12,ANAPC10,ANAPC11,ANAPC13,BAD,Calm1 (includes others),CREB3,CREM,DUSP1,DUSP11,DUSP7,GDE1,GNAS,GNB2,GNG11,GNG5,GSK3A,H3-3A/H3-3B,KDELR1,KDELR2,MAPK3,MYL11,MYL12A,MYL12B,NFKBIA,NOTUM,PDE2A,PGP,PPP1R11,PRKAG1,PTPRR,RAP1A,RHOA,SMPDL3A,TCF3,Tcf7,VASP,YWHAE,YWHAH,YWHAQ	
CXCR4 Signaling	3.4E00	1.25E-01	-4.000	Cdc42,CXCL12,FOS,GNA11,GNAS,GNB2,GNG11,GNG5,HRAS,JUN,MAPK3,MYL11,MYL12A,MYL12B,RAP1A,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS	
TP53 Regulates Transcription of DNA Repair Genes	3.38E00	1.71E-01	-3.464	AP1M1,CDK9,ELOC,FOS,JUN,NELFE,POLR2C,POLR2D,POLR2E,POLR2I,POLR2K,SUPT4H1	
Glucocorticoid Receptor Signaling	3.34E00	8.93E-02	NaN	ACTB,ADRB2,CDKN1A,CREBZF,CYC1,DUSP1,FKBP4,FOS,GTF2A2,GTF2B,H2-T22,H3-3A/H3-3B,HLA-A,HLA-E,HRAS,HSPA1A/HSPA1B,Hspa1b,HSPA8,IL10RB,JUN,MAPK3,NDUFA3,NDUFA6,NDUFA7,NDUFB10,NDUFB11,NDUFS2,NDUFS3,NFKBIA,POLR2C,POLR2D,POLR2E,POLR2I,POLR2K,POMC,PRKAB1,PRKAG1,RAP1A,RARG,RASD1,RRAS,SDHB,SDHD,SGK1,SMARCB1,SUMO1,TAF11,TAF7,TSC22D3,UBE2I,UQCRFS1,YWHAH	
Fc epsilon receptor (FCERI) signaling	3.34E00	1.17E-01	-4.796	BCL10,FOS,HRAS,JUN,MAPK3,NFKBIA,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,RASGRP2,RASGRP4,SEM1,UBC,UBE2N,UBE2V1	
Interferon alpha/beta signaling	3.33E00	1.69E-01	-3.464	GBP2,HLA-A,HLA-E,IFI35,IFIT3,IFNAR2,IRF1,IRF7,ISG15,RSAD2,USP18,XAF1	
Aggrephagy	3.32E00	2.09E-01	-3.000	DYNLL1,TUBA1A,TUBA1B,TUBB2A,TUBB4B,UBC,UBE2N,UBE2V1,VIM	
Sumoylation Pathway	3.28E00	1.46E-01	0.000	ARHGDIA,Cdc42,FAS,FOS,JUN,NFKBIA,RHOA,RHOB,RHOC,RHOG,STUB1,SUMO1,SUMO2,UBA2,UBE2I	
Ephrin B Signaling	3.27E00	1.67E-01	-2.646	CFL1,CFL2,CXCL12,GNA11,GNAS,GNB2,GNG11,GNG5,HNRNPK,HRAS,MAPK3,RHOA	
HIF1α Signaling	3.25E00	1.15E-01	-2.041	CAMK1,CCNG2,CDKN1A,COPS5,EDN1,EGLN2,EIF4E,ELOC,HRAS,HSPA1A/HSPA1B,Hspa1b,HSPA8,JUN,LDHA,MAPK3,MKNK2,PDGFB,RAP1A,RASD1,RRAS,SAT1,SLC2A1,STUB1,VIM	
Signaling by TGF-beta Receptor Complex	3.25E00	1.89E-01	-3.162	BAMBI,F11R,LTBP4,PMEPA1,PPP1R15A,RHOA,STRAP,STUB1,UBC,UBE2M	
Actin Nucleation by ARP-WASP Complex	3.25E00	1.51E-01	-3.464	ARPC1A,ARPC4,ARPC5L,BAIAP2,Cdc42,HRAS,RAP1A,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,VASP	
Regulation of mRNA stability by proteins that bind AU-rich elements	3.25E00	2.05E-01	-3.000	ENPP2,EXOSC1,EXOSC8,HSPA1A/HSPA1B,HSPA8,HSPB1,TNFSF13,UBC,ZFP36	
TBC/RABGAPs	3.25E00	2.05E-01	-3.000	ARF6,GABARAP,GABARAPL2,MAP1LC3B,RAB11B,RAB4A,RAB5A,TBC1D10A,TBC1D10B	
Senescence-Associated Secretory Phenotype (SASP)	3.21E00	1.64E-01	-3.464	ANAPC10,ANAPC11,ANAPC16,CDKN1A,CDKN1B,CDKN2B,CDKN2D,FOS,JUN,MAPK3,UBC,UBE2S	
RHO GTPases activate PKNs	3.19E00	2.5E-01	-2.646	MYL12B,RHOA,RHOB,RHOC,YWHAE,YWHAH,YWHAQ	
MicroRNA Biogenesis Signaling Pathway	3.17E00	1.18E-01	-4.690	DDX5,DNAJA2,DNAJB1,EXOSC1,EXOSC8,GLE1,HRAS,HSPA8,MAPK3,PDGFB,POLR2C,POLR2D,POLR2E,POLR2I,POLR2K,PRKRA,RAP1A,RASD1,RRAS,SEC13,SRSF3,ST13	
ERK5 Signaling	3.16E00	1.62E-01	-2.714	BAD,CREB3,FOS,HRAS,MAP3K8,RAP1A,RASD1,RRAS,SGK1,YWHAE,YWHAH,YWHAQ	
The citric acid (TCA) cycle and respiratory electron transport	3.12E00	1.82E-01	-3.162	BSG,HAGH,IDH3G,LDHA,MDH2,MPC1,PDHB,SDHB,SDHD,VDAC1	
Cargo recognition for clathrin-mediated endocytosis	3.1E00	1.4E-01	-3.873	ADRB2,AP2A2,CLTA,COPS4,COPS5,COPS8,GPS1,NECAP2,SH3GL1,TFRC,TOR1A,UBC,VAMP3,VAMP7,VAMP8	
Clathrin-mediated endocytosis	3.09E00	1.31E-01	-4.123	ACTB,ACTG1,ADRB2,AP2A2,ARF6,ARPC1A,ARPC4,CLTA,HSPA8,NECAP2,RAB5A,SH3GL1,TFRC,UBC,VAMP3,VAMP7,VAMP8	
Protein Sorting Signaling Pathway	3.07E00	1.18E-01	-4.583	AP1M1,ARF1,CLTA,COPZ1,GNAS,KDELR1,KDELR2,PRKAG1,RAB11B,RER1,SEC13,SNX11,SNX15,SNX16,SNX17,SNX21,SNX3,TMED2,TMED4,TMED9,VPS29	
RHO GTPases Activate Rhotekin and Rhophilins	3.03E00	4.44E-01	-2.000	RHOA,RHOB,RHOC,TAX1BP3	
Lipophagy	3.03E00	4.44E-01	-2.000	HSPA8,PLIN3,PRKAB1,PRKAG1	
TP53 Regulates Metabolic Genes	2.98E00	1.48E-01	-3.606	COX19,COX5A,COX7A2L,LAMTOR1,PRKAB1,PRKAG1,RHEB,RRAGA,RRAGC,SURF1,YWHAE,YWHAH,YWHAQ	
Renal Cell Carcinoma Signaling	2.9E00	1.52E-01	-2.449	ELOC,FOS,HRAS,JUN,MAPK3,PDGFB,RAP1A,RASD1,RRAS,SLC2A1,Ubb,UBC	
Cardiac Hypertrophy Signaling	2.88E00	1.03E-01	-4.491	ADRB2,Calm1 (includes others),Cdc42,EIF2B4,EIF4E,GNA11,GNAS,GNB2,GNG11,GNG5,HRAS,HSPB1,JUN,MAP3K8,MAPK3,MYL11,MYL12A,MYL12B,NOTUM,PRKAG1,RAP1A,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS	
Ceramide Signaling	2.84E00	1.43E-01	-3.317	BAD,CTSD,FOS,HRAS,JUN,MAPK3,PPP2CB,RAP1A,RASD1,RRAS,S1PR1,S1PR4,SMPD2	
Assembly of RNA Polymerase II Complex	2.83E00	1.8E-01	-3.000	GTF2A2,GTF2B,POLR2C,POLR2D,POLR2E,POLR2I,POLR2K,TAF11,TAF7	
Role of MAPK Signaling in Promoting the Pathogenesis of Influenza	2.82E00	1.32E-01	-3.051	ATP6V0B,ATP6V0C,ATP6V0D1,ATP6V0E1,ATP6V1F,ATP6V1G1,HRAS,JUN,MAPK3,NFKBIA,PNPLA2,PRDX6,RAP1A,RASD1,RRAS	
Chemokine Signaling	2.8E00	1.48E-01	-2.714	Calm1 (includes others),CAMK1,CFL1,CXCL12,FOS,HRAS,JUN,MAPK3,RAP1A,RASD1,RHOA,RRAS	
Regulation of Actin-based Motility by Rho	2.78E00	1.3E-01	-3.606	ACTB,ARHGDIA,ARPC1A,ARPC4,ARPC5L,BAIAP2,Cdc42,CFL1,MYL11,MYL12A,MYL12B,RHOA,RHOB,RHOC,RHOG	
ISG15 antiviral mechanism	2.77E00	1.55E-01	-3.317	EIF4A1,EIF4A3,EIF4E,EIF4E2,ISG15,MAPK3,PIN1,SEC13,UBC,UBE2L6,UBE2N	
ILK Signaling	2.76E00	1.09E-01	-3.300	ACTB,ACTG1,Cdc42,CFL1,CFL2,CREB3,FERMT2,FOS,GSK3A,ILK,ILKAP,JUN,LIMS2,MAPK3,NACA,PPP2CB,RHOA,RHOB,RHOC,RHOG,TGFB1I1,VIM	
FOXO-mediated transcription of cell cycle genes	2.74E00	2.94E-01	-2.236	BTG1,CCNG2,CDKN1A,CDKN1B,KLF4	
Signaling by Rho Family GTPases	2.74E00	1.01E-01	-4.025	ACTB,ACTG1,ARPC1A,ARPC4,ARPC5L,BAIAP2,Cdc42,CDC42EP1,CFL1,CFL2,FOS,GNA11,GNAS,GNB2,GNG11,GNG5,JUN,MAPK3,MYL11,MYL12A,MYL12B,RHOA,RHOB,RHOC,RHOG,STMN1,VIM	
EPH-Ephrin signaling	2.71E00	1.38E-01	-3.606	ACTB,ACTG1,AP2A2,ARPC1A,ARPC4,CFL1,CLTA,EFNA1,HRAS,MYL12A,MYL12B,PSENEN,RHOA	
Cilium Assembly	2.68E00	1.08E-01	-4.690	ARF4,BBIP1,CCT4,CCT5,CCT8,CEP57,CETN2,CSNK1E,DCTN2,DCTN3,DYNLL1,DYNLRB1,EXOC7,IFT20,LZTFL1,SSNA1,TUBA1A,TUBA1B,TUBB,TUBB2A,TUBB4B,YWHAE	
Signaling by FGFR2	2.67E00	1.51E-01	-3.317	HNRNPF,HRAS,MAPK3,NCBP2,POLR2C,POLR2D,POLR2E,POLR2I,POLR2K,PPP2CB,UBC	
Transcriptional regulation of white adipocyte differentiation	2.67E00	1.43E-01	-3.464	CCNC,CDK8,KLF4,MED10,MED20,MED21,MED28,MED31,MED4,MED7,MED8,MED9	
Signaling by Insulin receptor	2.66E00	1.86E-01	-2.828	ATP6V0B,ATP6V0C,ATP6V0D1,ATP6V0E1,ATP6V1F,ATP6V1G1,HRAS,MAPK3	
Gap junction trafficking and regulation	2.65E00	2.06E-01	-2.646	ACTB,ACTG1,CLTA,TUBA1A,TUBA1B,TUBB2A,TUBB4B	
Late endosomal microautophagy	2.65E00	2.06E-01	-2.646	CHMP2B,CHMP6,HSPA8,MVB12A,PLIN3,UBC,VIM	
Processing and activation of SUMO	2.65E00	3.64E-01	-2.000	SUMO1,SUMO2,UBA2,UBE2I	
Peroxisomal protein import	2.65E00	1.59E-01	-3.162	ACAA1,GSTK1,HMGCL,MLYCD,MPV17,PEX13,PEX2,SCP2,UBC,UBE2D3	
Clathrin-mediated Endocytosis Signaling	2.57E00	1.06E-01	NaN	ACTB,ACTG1,AP1M1,AP2A2,APOD,APOE,ARF6,ARPC1A,ARPC4,ARPC5L,CLTA,CSNK2B,HSPA8,PDGFB,RAB11B,RAB4A,RAB5A,SH3GL1,SH3GLB1,TFRC,Ubb,UBC	
Insulin Secretion Signaling Pathway	2.56E00	9.82E-02	-5.196	BET1L,CPE,CREB3,EIF2B4,EIF2S2,EIF4A1,EIF4A3,EIF4E,GNA11,GNAS,MAPK3,NAPA,NOTUM,PDHB,PRKAG1,RAP1A,SEC11A,SEC61G,SLC2A1,SPCS1,SPCS2,SRP14,SRP9,SSR2,TCF3,VAMP3,VTI1B	
RAF/MAP kinase cascade	2.54E00	9.92E-02	-5.000	ACTB,ACTG1,DUSP1,DUSP7,HRAS,MAPK3,PDGFB,PPP2CB,PPP5C,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,RAP1A,RASGRP4,RGL2,SEM1,UBC	
Deadenylation-dependent mRNA decay	2.53E00	1.64E-01	-3.000	CNOT3,CNOT8,EIF4A1,EIF4A3,EIF4E,EXOSC1,EXOSC8,LSM3,LSM5	
Sertoli Cell-Germ Cell Junction Signaling Pathway (Enhanced)	2.53E00	1.02E-01	-1.225	ACTB,ACTG1,ARPC1A,ARPC4,ARPC5L,CLDN5,F11R,FOS,FOSB,GSK3A,HRAS,ILK,JUN,JUP,MAP3K8,MAPK3,OCLN,PPP2CB,PRKAB1,PRKAG1,RAP1A,RASD1,RRAS,ZYX	
Formaldehyde Oxidation II (Glutathione-dependent)	2.52E00	1E00	NaN	ADH5,ESD	
RHO GTPases activate CIT	2.51E00	2.63E-01	-2.236	CDKN1B,MYL12B,RHOA,RHOB,RHOC	
RHO GTPases Activate ROCKs	2.51E00	2.63E-01	-2.236	CFL1,MYL12B,RHOA,RHOB,RHOC	
Antiproliferative Role of Somatostatin Receptor 2	2.49E00	1.43E-01	-1.414	CDKN1A,CDKN1B,GNB2,GNG11,GNG5,HRAS,MAPK3,NT5C,RAP1A,RASD1,RRAS	
TCF dependent signaling in response to WNT	2.47E00	1.06E-01	-4.583	CBY1,CSNK1E,CSNK2B,PPP2CB,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,SEM1,SOX17,SOX7,TLE5,UBC	
PI3K/AKT Signaling	2.44E00	1.05E-01	-1.886	BAD,CDKN1A,CDKN1B,EIF4E,GSK3A,HRAS,IL10RB,ILK,INPP5K,MAP3K8,MAPK3,MCL1,NFKBIA,PPP2CB,RAP1A,RASD1,RHEB,RRAS,YWHAE,YWHAH,YWHAQ	
Gene and protein expression by JAK-STAT signaling after IL-12 stimulation	2.43E00	1.89E-01	0.378	ARF1,CFL1,CNN2,HNRNPF,PDCD4,RPLP0,TALDO1	
MTOR signalling	2.43E00	2.14E-01	-2.449	AKT1S1,EIF4E,LAMTOR1,RHEB,RRAGA,RRAGC	
Glutathione Redox Reactions I	2.43E00	2.14E-01	-2.449	GPX1,GPX4,GSTK1,GSTM2,GSTT2/GSTT2B,PRDX6	
DNA Damage Bypass	2.35E00	1.67E-01	-2.828	ISG15,MAD2L2,POLD4,RCHY1,RPA3,UBC,UBE2B,UBE2L6	
Energy dependent regulation of mTOR by LKB1-AMPK	2.35E00	2.07E-01	-2.449	LAMTOR1,PRKAB1,PRKAG1,RHEB,RRAGA,RRAGC	
mRNA Capping	2.35E00	2.07E-01	-2.449	NCBP2,POLR2C,POLR2D,POLR2E,POLR2I,POLR2K	
Coronavirus Pathogenesis Pathway	2.34E00	1.03E-01	2.837	EIF4E,FAU,FOS,IFNAR2,IRF7,JUN,MAPK3,NFKBIA,RPS10,RPS13,RPS15A,RPS20,RPS21,RPS24,RPS26,RPS28,RPS29,RPS4Y1,RPS5,RPS7,RPS9	
Apelin Endothelial Signaling Pathway	2.31E00	1.13E-01	-3.317	Calm1 (includes others),FOS,GNA11,GNAS,GNB2,GNG11,GNG5,HRAS,JUN,KLF2,MAPK3,PRKAB1,PRKAG1,RAP1A,RASD1,RRAS	
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	2.3E00	1.63E-01	-2.828	CCNC,CDK8,CDK9,CDKN2B,JUNB,MAPK3,SKIL,UBC	
fMLP Signaling in Neutrophils	2.23E00	1.15E-01	-2.887	ARPC1A,ARPC4,ARPC5L,Calm1 (includes others),GNA11,GNAS,GNB2,GNG11,GNG5,HRAS,MAPK3,NFKBIA,RAP1A,RASD1,RRAS	
Semaphorin Signaling in Neurons	2.22E00	1.48E-01	NaN	Cdc42,CFL1,CFL2,DPYSL2,MAPK3,RHOA,RHOB,RHOC,RHOG	
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane	2.22E00	2.27E-01	-2.236	CAMLG,SEC61G,SGTA,UBL4A,VAPA	
RHO GTPases activate IQGAPs	2.2E00	1.94E-01	-2.449	ACTB,ACTG1,TUBA1A,TUBA1B,TUBB2A,TUBB4B	
Endosomal Sorting Complex Required For Transport (ESCRT)	2.2E00	1.94E-01	-2.449	CHMP2B,CHMP5,CHMP6,MVB12A,UBC,VTA1	
UVC-Induced MAPK Signaling	2.19E00	1.57E-01	-2.646	FOS,HRAS,JUN,MAPK3,RAP1A,RASD1,RRAS,SMPD2	
Extra-nuclear estrogen signaling	2.18E00	1.37E-01	-3.162	CAV2,CDKN1B,FOS,GNB2,GNG11,GNG5,HRAS,HSPB1,MAPK3,PRMT1	
Glioma Invasiveness Signaling	2.18E00	1.37E-01	-2.828	Cdc42,HRAS,MAPK3,RAP1A,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS	
TCA Cycle II (Eukaryotic)	2.13E00	2.17E-01	-2.236	IDH3G,MDH1,MDH2,SDHB,SDHD	
Cachexia Signaling Pathway	2.12E00	8.7E-02	-4.950	ADRB2,CASP6,EIF2B4,EIF2S2,GNAS,GSK3A,HSPA1A/HSPA1B,Hspa1b,HSPA8,IFNGR1,MALAT1,MAP1LC3B,MAPK3,PNPLA2,POMC,PRKAB1,PRKAG1,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,S1PR1,TNFSF12,TNFSF13	
Role of PKR in Interferon Induction and Antiviral Response	2.09E00	1.1E-01	-1.604	ATF3,CYC1,FAS,FOS,HSPA1A/HSPA1B,Hspa1b,HSPA8,IFNAR2,IFNGR1,IRF1,JUN,MAPK3,NFKBIA,PDGFB,PRKRA	
Ephrin Receptor Signaling	2.08E00	9.9E-02	-4.123	ARPC1A,ARPC4,ARPC5L,CFL1,CFL2,CREB3,CXCL12,EFNA1,GNA11,GNAS,GNB2,GNG11,GNG5,HRAS,MAPK3,PDGFB,RAP1A,RASD1,RHOA,RRAS	
RHOA Signaling	2.07E00	1.13E-01	-3.742	ACTB,ACTG1,ARPC1A,ARPC4,ARPC5L,BAIAP2,CDC42EP1,CFL1,CFL2,LPAR6,MYL11,MYL12A,MYL12B,RHOA	
SUMOylation of nuclear envelope proteins	2.06E00	6.67E-01	NaN	SUMO1,UBE2I	
S-adenosyl-L-methionine Biosynthesis	2.06E00	6.67E-01	NaN	MAT2A,MAT2B	
Mitotic Prometaphase	2.05E00	9.85E-02	-4.472	BUB3,CEP57,CETN2,CSNK1E,CSNK2B,DCTN2,DCTN3,DYNLL1,MZT1,NDEL1,NUDC,PPP2CB,SEC13,SSNA1,TUBA1A,TUBA1B,TUBB,TUBB2A,TUBB4B,YWHAE	
RAS processing	2.05E00	2.08E-01	-2.236	ABHD17A,FNTA,HRAS,RCE1,UBC	
ERB2-ERBB3 Signaling	2.04E00	1.38E-01	-0.816	BAD,CDKN1B,GSK3A,HRAS,JUN,MAPK3,RAP1A,RASD1,RRAS	
Iron homeostasis signaling pathway	2.03E00	1.09E-01	NaN	ATP6V0B,ATP6V0C,ATP6V0D1,ATP6V0E1,ATP6V1F,ATP6V1G1,CIAO1,CIAO2A,FTL,ISCU,MAPK3,PCBP1,PDGFB,SLC40A1,TFRC	
RHO GTPases Activate Formins	2E00	1.08E-01	-3.873	ACTB,ACTG1,BUB3,DYNLL1,NDEL1,NUDC,PPP2CB,RHOA,RHOB,RHOC,SEC13,TUBA1A,TUBA1B,TUBB2A,TUBB4B	
RHOGDI Signaling	1.98E00	9.55E-02	2.500	ACTB,ACTG1,ARHGDIA,ARPC1A,ARPC4,ARPC5L,Cdc42,CFL1,CFL2,GNA11,GNAS,GNB2,GNG11,GNG5,MYL11,MYL12A,MYL12B,RHOA,RHOB,RHOC,RHOG	
CGAS-STING Signaling Pathway	1.98E00	1.07E-01	-3.357	ATG5,ATP6V0B,ATP6V0C,ATP6V0D1,ATP6V0E1,ATP6V1F,ATP6V1G1,CDKN1A,IRF1,LRRC8A,MAP1LC3A,MAP1LC3B,NFKBIA,TNFSF12,TNFSF13	
MSP-RON Signaling in Cancer Cells Pathway	1.98E00	1.07E-01	-3.357	CREB3,FOS,HRAS,JUN,MAPK3,NFKBIA,RAP1A,RASD1,RRAS,TCF3,Tcf7,VIM,YWHAE,YWHAH,YWHAQ	
Unfolded protein response	1.97E00	1.22E-01	-2.449	DNAJA1,DNAJA2,DNAJA4,DNAJB1,DNAJB9,HSPA1A/HSPA1B,Hspa1b,HSPA8,NFE2L2,PDIA6,PPP1R15A	
Heme Biosynthesis II	1.96E00	3.33E-01	NaN	ALAD,ALAS1,UROD	
Coronavirus Replication Pathway	1.96E00	1.56E-01	-2.646	COPZ1,GSK3A,TUBA1A,TUBA1B,TUBB,TUBB2A,TUBB4B	
Hepatic Fibrosis Signaling Pathway	1.94E00	8.27E-02	-3.656	BAMBI,Calm1 (includes others),CCN2,CD40,Cdc42,CDKN1B,CREB3,CSNK1E,EDN1,EZH2,FOS,FTL,HRAS,JUN,KLF9,MAPK3,MYL11,MYL12A,MYL12B,NFKBIA,PDCD4,PDGFB,PRKAG1,RAP1A,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,SDHB,SDHD,TCF3,Tcf7,TFRC	
Nucleotide Excision Repair Pathway	1.94E00	1.71E-01	NaN	POLR2C,POLR2D,POLR2E,POLR2I,POLR2K,RPA3	
Acute Myeloid Leukemia Signaling	1.94E00	1.21E-01	-1.890	BAD,HRAS,IDH3G,JUP,MAPK3,PIM1,RAP1A,RASD1,RRAS,TCF3,Tcf7	
Hereditary Breast Cancer Signaling	1.92E00	1.06E-01	NaN	ACTB,CDKN1A,GADD45G,HRAS,POLR2C,POLR2D,POLR2E,POLR2I,POLR2K,RAP1A,RASD1,RRAS,SMARCB1,Ubb,UBC	
Opioid Signaling Pathway	1.9E00	8.93E-02	-2.357	AP2A2,BAD,Calm1 (includes others),CAMK1,CDKN1B,CLTA,CREB3,FOS,FOSB,GNA11,GNAS,GNB2,GNG11,GNG5,HRAS,MAPK3,NFKBIA,OGFR,POMC,PRKAG1,RAP1A,RASD1,RGS12,RRAS,TCF3	
IL-8 Signaling	1.9E00	9.52E-02	-3.742	Cdc42,FOS,GNA11,GNAS,GNB2,GNG11,GNG5,HRAS,JUN,MAPK3,MYL12B,NFKBIA,RAP1A,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,VASP	
Signaling by the B Cell Receptor (BCR)	1.88E00	1E-01	-4.123	BCL10,HRAS,NFKBIA,PSMA1,PSMA5,PSMA6,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC6,PSMD13,PSMD6,PSMD8,SEM1,UBC	
RHO GTPases Activate WASPs and WAVEs	1.88E00	1.67E-01	-2.449	ACTB,ACTG1,ARPC1A,ARPC4,BAIAP2,MAPK3	
Interferon Signaling	1.88E00	1.67E-01	-2.449	IFI35,IFIT3,IFNAR2,IFNGR1,IRF1,ISG15	
Gap Junction Signaling	1.87E00	8.62E-02	-3.780	ACTB,ACTG1,Calm1 (includes others),CDKN1B,CREB3,CSNK1E,GNAS,GSK3A,HRAS,HSPA8,LPAR6,MAPK3,NOTUM,NT5C,PRKAG1,RAP1A,RASD1,RRAS,TCF3,Tcf7,TUBA1A,TUBA1B,TUBB,TUBB2A,TUBB4B,VDAC1,VDAC2,VDAC3	
Activation of anterior HOX genes in hindbrain during early embryogenesis	1.87E00	1.23E-01	-3.162	DPY30,EZH2,JUN,POLR2C,POLR2D,POLR2E,POLR2I,POLR2K,RARG,RBBP4	
Regulation of lipid metabolism by PPARalpha	1.85E00	1.09E-01	-3.051	ALAS1,CCNC,CDK8,MED10,MED20,MED21,MED28,MED31,MED4,MED7,MED8,MED9,NR1H2	
Cholecystokinin/Gastrin-mediated Signaling	1.85E00	1.09E-01	-3.317	Cdc42,CREM,FOS,HRAS,JUN,MAPK3,RAP1A,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS	
Tryptophan Degradation X (Mammalian, via Tryptamine)	1.83E00	1.85E-01	-2.236	AKR1A1,ALDH2,DDC,RDH14,SMOX	
Gluconeogenesis I	1.83E00	1.85E-01	-2.236	ALDOA,ENO1,MDH1,MDH2,PGAM1	
Apelin Muscle Signaling Pathway	1.81E00	1.46E-01	NaN	GNA11,GNAS,GNB2,GNG11,GNG5,PRKAB1,PRKAG1	
Endocannabinoid Cancer Inhibition Pathway	1.8E00	1.02E-01	-0.775	AKT1S1,ATF3,BAD,CASP6,CDKN1A,CDKN1B,CREB3,MAPK3,PRKAB1,PRKAG1,RHOA,SMPD2,TCF3,Tcf7,VIM	
CCR3 Signaling in Eosinophils	1.79E00	1.04E-01	-2.236	Calm1 (includes others),CFL1,CFL2,GNA11,GNAS,GNB2,GNG11,GNG5,HRAS,MAPK3,RAP1A,RASD1,RHOA,RRAS	
Glutathione-mediated Detoxification	1.77E00	1.58E-01	-2.449	GGH,Gsta4,GSTK1,GSTM2,GSTM5,GSTT2/GSTT2B	
Spermine and Spermidine Degradation I	1.77E00	5E-01	NaN	SAT1,SMOX	
N-acetylglucosamine Degradation II	1.77E00	5E-01	NaN	GNPDA2,NAGK	
α-Adrenergic Signaling	1.77E00	1.1E-01	-2.449	Calm1 (includes others),GNA11,GNAS,GNB2,GNG11,GNG5,HRAS,MAPK3,PRKAG1,RAP1A,RASD1,RRAS	
RNA Polymerase I Transcription	1.72E00	1.4E-01	-2.646	MAPK3,MBD3,POLR1D,POLR2E,POLR2K,RBBP4,UBTF	
Melanoma Signaling	1.72E00	1.4E-01	-0.816	BAD,CDKN1A,HRAS,MAPK3,RAP1A,RASD1,RRAS	
SUMOylation of immune response proteins	1.7E00	2.73E-01	NaN	NFKBIA,SUMO1,UBE2I	
Pexophagy	1.7E00	2.73E-01	NaN	MAP1LC3B,SQSTM1,UBC	
Dolichyl-diphosphooligosaccharide Biosynthesis	1.7E00	2.73E-01	NaN	DPM1,DPM2,DPM3	
Superpathway of Cholesterol Biosynthesis	1.7E00	1.72E-01	-2.236	EBP,FDPS,HADHB,MSMO1,PMVK	
UFMylation Signaling Pathway	1.69E00	1.29E-01	-2.828	ABCG1,DDRGK1,EIF4A1,EIF4A3,EIF4E,GPX4,H3-3A/H3-3B,UBA5	
IL-2 Signaling	1.69E00	1.29E-01	-2.236	CSNK2B,FOS,HRAS,JUN,MAPK3,RAP1A,RASD1,RRAS	
Granzyme A Signaling	1.69E00	1.22E-01	3.000	HMGB2,NDUFA1,NDUFA3,NDUFA6,NDUFA7,NDUFB10,NDUFB11,NDUFS2,NDUFS3	
VEGF Signaling	1.69E00	1.11E-01	-1.890	ACTB,ACTG1,BAD,EIF2B4,EIF2S2,HRAS,MAPK3,RAP1A,RASD1,RRAS,YWHAE	
PDGF Signaling	1.67E00	1.15E-01	-3.000	CSNK2B,FOS,HRAS,INPP5K,JUN,MAPK3,PDGFB,RAP1A,RASD1,RRAS	
SUMOylation of transcription factors	1.66E00	2E-01	-2.000	FOXL2,SUMO1,SUMO2,UBE2I	
Synthesis, secretion, and deacylation of Ghrelin	1.66E00	2E-01	-2.000	KLF4,SEC11A,SPCS1,SPCS2	
Class I peroxisomal membrane protein import	1.66E00	2E-01	-2.000	PEX13,PEX2,PEX3,SLC25A17	
HMGB1 Signaling	1.65E00	9.58E-02	-3.464	Cdc42,FOS,HRAS,IFNGR1,JUN,MAPK3,PLAT,RAP1A,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,TNFSF12,TNFSF13	
Regulation of TP53 Activity through Acetylation	1.64E00	1.67E-01	-2.236	MBD3,MEAF6,PIN1,PIP4P1,RBBP4	
Protein ubiquitination	1.64E00	1.67E-01	-2.236	UBC,UBE2A,UBE2B,UBE2G2,UBE2S	
Endocannabinoid Developing Neuron Pathway	1.63E00	1.02E-01	-2.530	AKT1S1,CDKN1B,CREB3,GNB2,GNG11,GNG5,HRAS,MAPK3,PRKAG1,RAP1A,RASD1,RHOA,RRAS	
Mechanisms of Viral Exit from Host Cells	1.62E00	1.46E-01	NaN	ACTB,ACTG1,CHMP2B,CHMP6,SH3GL1,SH3GLB1	
Circadian Rhythm Signaling	1.61E00	8.58E-02	NaN	AKT1S1,CIRBP,CREB3,CSNK1E,EIF4E,GNA11,GNAS,GNB2,GNG11,GNG5,GSK3A,H3-3A/H3-3B,HRAS,MAPK3,MKNK2,NOTUM,NT5C,PER1,PRKAB1,PRKAG1,RAP1A,RASD1,RRAS	
Thrombin Signaling	1.61E00	8.89E-02	-3.317	CAMK1,Cdc42,GNA11,GNAS,GNB2,GNG11,GNG5,HRAS,MAPK3,MYL11,MYL12A,MYL12B,NOTUM,RAP1A,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS	
Relaxin Signaling	1.61E00	9.68E-02	-2.333	FOS,GDE1,GNA11,GNAS,GNB2,GNG11,GNG5,JUN,MAPK3,NFKBIA,NT5C,PDE2A,PRKAG1,RAP1A,SMPDL3A	
RAB GEFs exchange GTP for GDP on RABs	1.61E00	1.12E-01	-3.162	CCZ1/CCZ1B,RAB18,RAB5A,RAB9A,TRAPPC1,TRAPPC2,TRAPPC3,TRAPPC4,TRAPPC5,YWHAE	
Sleep NREM Signaling Pathway	1.6E00	1.04E-01	3.464	ADRB2,CREB3,GNAS,HRAS,MAPK3,PRKAG1,RAP1A,RASD1,RRAS,YWHAE,YWHAH,YWHAQ	
Reversible hydration of carbon dioxide	1.6E00	2.5E-01	NaN	CA14,CA2,CA4	
Spliceosomal Cycle	1.59E00	1.32E-01	-2.646	BCAS2,DDX39B,EIF4A3,HSPA8,RBM8A,SF3B4,SF3B6	
Activation of IRF by Cytosolic Pattern Recognition Receptors	1.58E00	1.23E-01	-0.707	CD40,IRF7,ISG15,JUN,NFKBIA,PIN1,PPIB,SIKE1	
Tetrapyrrole Biosynthesis II	1.57E00	4E-01	NaN	ALAD,ALAS1	
Colorectal Cancer Metastasis Signaling	1.56E00	8.49E-02	-3.441	BAD,Cdc42,FOS,GNA11,GNAS,GNB2,GNG11,GNG5,HRAS,IFNGR1,JUN,MAPK3,PRKAG1,RAP1A,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,SIAH1,TCF3,Tcf7	
Neurotrophin/TRK Signaling	1.56E00	1.15E-01	-2.121	CREB3,FOS,HRAS,JUN,MAPK3,RAP1A,RASD1,RRAS,SPRY1	
Apelin Adipocyte Signaling Pathway	1.55E00	1.1E-01	-3.162	GNA11,GPX1,GPX4,GSTK1,GSTM2,GSTT2/GSTT2B,MAPK3,PRDX6,PRKAB1,PRKAG1	
Apoptosis Signaling	1.55E00	1.06E-01	0.333	BAD,CASP6,CYC1,FAS,HRAS,MAPK3,MCL1,NFKBIA,RAP1A,RASD1,RRAS	
Serotonin Receptor Signaling	1.53E00	7.68E-02	-5.000	ADRB2,Calm1 (includes others),CAV2,Cdc42,COPS5,CPE,CREB3,DDC,EDN1,GNA11,GNAS,GNB2,GNG11,GNG5,H3-3A/H3-3B,HRAS,JUN,MAP1LC3B,MAPK3,NFKBIA,NOTUM,OCLN,PNPLA2,PRDX6,PRKAG1,RAB4A,RAP1A,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,SMOX,SPR,SQSTM1	
Toll Like Receptor 3 (TLR3) Cascade	1.53E00	1.56E-01	-2.236	IRF7,UBC,UBE2D3,UBE2N,UBE2V1	
Thrombin signalling through proteinase activated receptors (PARs)	1.53E00	1.56E-01	-2.236	GNA11,GNB2,GNG11,GNG5,MAPK3	
DDX58/IFIH1-mediated induction of interferon-alpha/beta	1.53E00	1.14E-01	-3.000	ATG5,IRF7,ISG15,NFKBIA,PIN1,SIKE1,UBC,UBE2D3,UBE2L6	
Thyroid Cancer Signaling	1.53E00	1.14E-01	-3.000	FOS,HRAS,JUN,MAPK3,RAP1A,RASD1,RRAS,TCF3,Tcf7	
Virus Entry via Endocytic Pathways	1.53E00	1.02E-01	NaN	ACTB,ACTG1,AP1M1,AP2A2,CLTA,HLA-A,HLA-E,HRAS,RAP1A,RASD1,RRAS,TFRC	
Aryl Hydrocarbon Receptor Signaling	1.52E00	9.43E-02	-0.333	ALDH2,CDKN1A,CDKN1B,CTSD,FAS,FOS,GSTK1,GSTM2,GSTM5,GSTT2/GSTT2B,HSPB1,JUN,MAPK3,NFE2L2,RARG	
ABRA Signaling Pathway	1.52E00	1.09E-01	-1.897	ACTB,ACTG1,CCN2,CFL1,CFL2,FOS,FOSB,JUNB,JUND,RHOA	
Cell junction organization	1.52E00	1.09E-01	-3.162	ACTB,ACTG1,CD151,CLDN5,F11R,FERMT2,ILK,JUP,LIMS2,VASP	
Chaperone Mediated Autophagy	1.52E00	1.82E-01	-2.000	HSPA8,PLIN3,UBC,VIM	
Intrinsic Pathway for Apoptosis	1.51E00	1.27E-01	-2.646	BAD,DYNLL1,MAPK3,NMT1,YWHAE,YWHAH,YWHAQ	
Mitochondrial iron-sulfur cluster biogenesis	1.5E00	2.31E-01	NaN	ISCA1,ISCA2,ISCU	
Dissolution of Fibrin Clot	1.5E00	2.31E-01	NaN	PLAT,SERPINB6,SERPINE2	
Advanced glycosylation endproduct receptor signaling	1.5E00	2.31E-01	NaN	CAPZA2,DDOST,MAPK3	
Mitochondrial calcium ion transport	1.5E00	2.31E-01	NaN	VDAC1,VDAC2,VDAC3	
Processing of SMDT1	1.5E00	2.31E-01	NaN	MAIP1,PHB2,PMPCB	
P2Y Purigenic Receptor Signaling Pathway	1.49E00	9.77E-02	-3.317	CREB3,FOS,GNB2,GNG11,GNG5,HRAS,JUN,MAPK3,NOTUM,PRKAG1,RAP1A,RASD1,RRAS	
Signal amplification	1.48E00	1.52E-01	-2.236	AAMP,GNA11,GNB2,GNG11,GNG5	
MAPK targets/ Nuclear events mediated by MAP kinases	1.48E00	1.52E-01	-2.236	DUSP7,FOS,JUN,MAPK3,PPP2CB	
Sphingosine-1-phosphate Signaling	1.48E00	1E-01	-2.714	CASP6,Cdc42,MAPK3,NOTUM,PDGFB,RHOA,RHOB,RHOC,RHOG,S1PR1,S1PR4,SMPD2	
Signaling by NTRK1 (TRKA)	1.47E00	1.11E-01	-3.000	AP2A2,CLTA,DUSP7,HRAS,MAPK3,PPP2CB,RAP1A,RHOA,RIT1	
Interferon gamma signaling	1.46E00	1.06E-01	-3.162	GBP2,GBP4,GBP5,HLA-A,HLA-E,IFNGR1,IRF1,IRF7,SUMO1,TRIM8	
Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes	1.46E00	1.06E-01	-3.162	ACTB,ACTG1,ARF6,ARPC1A,ARPC4,ARPC5L,MAPK3,RAB11B,VAMP3,VASP	
Metabolism of porphyrins	1.45E00	1.74E-01	-2.000	ABCG2,ALAD,ALAS1,UROD	
Agrin Interactions at Neuromuscular Junction	1.45E00	1.16E-01	-2.646	ACTB,ACTG1,HRAS,JUN,MAPK3,RAP1A,RASD1,RRAS	
Production of Nitric Oxide and Reactive Oxygen Species in Macrophages	1.45E00	8.9E-02	-2.840	APOD,APOE,Cdc42,FOS,IFNGR1,IRF1,JUN,MAP3K8,MAPK3,NFKBIA,PPP1R11,PPP2CB,RAP1A,RHOA,RHOB,RHOC,RHOG	
ISGylation Signaling Pathway	1.44E00	1.02E-01	-2.111	CHMP5,EIF4E2,IFNAR2,IL10RB,IRF1,IRF7,ISG15,SQSTM1,UBE2L6,UBE2N,USP18	
JAK/STAT Signaling	1.44E00	1.1E-01	-1.414	CDKN1A,FOS,HRAS,JUN,MAPK3,RAP1A,RASD1,RRAS,SOCS2	
BEX2 Signaling Pathway	1.44E00	1.1E-01	-0.333	BAD,CDKN1A,JUN,LMO2,NFKBIA,PPP2CB,SMARCB1,TCF3,Tcf7	
Oncogene Induced Senescence	1.43E00	1.47E-01	-2.000	CDKN2B,CDKN2D,ID1,MAPK3,UBC	
Cargo concentration in the ER	1.43E00	1.47E-01	-2.236	CNIH1,CTSC,LMAN2L,SAR1B,TMED2	
Transcriptional Regulation by E2F6	1.43E00	1.47E-01	NaN	CBX3,EZH2,MAX,RBBP4,RNF2	
Fatty Acid β-oxidation I	1.43E00	1.47E-01	-2.236	ACAA1,ECHS1,ECI1,HADHB,SCP2	
Eicosanoid Signaling	1.42E00	8.21E-02	-3.962	AP1M1,BAD,CREB3,GNA11,GNAS,GNB2,GNG11,GNG5,GSK3A,HRAS,HSPB1,KLF4,MAPK3,NOTUM,PNPLA2,PRDX6,PRKAG1,RAP1A,RASD1,RHOA,RRAS,TCF3,Tcf7	
Axonal Guidance Signaling	1.42E00	7.45E-02	NaN	ADAMTS10,ARPC1A,ARPC4,ARPC5L,BAIAP2,CFL1,CFL2,COPS5,CXCL12,DPYSL2,EFNA1,EIF3F,EIF3H,EIF4E,GNA11,GNAS,GNB2,GNG11,GNG5,HRAS,MAPK3,MYL11,MYL12A,MYL12B,NOTUM,PDGFB,PMPCB,PRKAG1,RAP1A,RASD1,RHOA,RRAS,TUBA1A,TUBA1B,TUBB,TUBB2A,TUBB4B,VASP	
3-phosphoinositide Degradation	1.41E00	8.81E-02	-3.606	ALPL,ATP1A2,DUSP1,DUSP11,ILKAP,INPP5K,MDP1,NOCT,NT5C,NUDT14,NUDT9,PIP4P1,PLPP6,PPP1R11,PPP2CB,PPP5C,PTPMT1	
SUMOylation of RNA binding proteins	1.4E00	1.3E-01	-2.449	HNRNPK,RNF2,SEC13,SUMO1,SUMO2,UBE2I	
RAC Signaling	1.4E00	9.49E-02	-3.464	ARPC1A,ARPC4,ARPC5L,BAIAP2,CFL1,CFL2,HRAS,JUN,MAPK3,RAP1A,RASD1,RHOA,RRAS	
PTEN Signaling	1.4E00	9.27E-02	0.832	BAD,CDKN1A,CDKN1B,CSNK2B,GSK3A,HRAS,ILK,INPP5K,MAPK3,MCRS1,RAP1A,RASD1,RRAS,YWHAH	
Mitochondrial Fatty Acid Beta-Oxidation	1.39E00	1.67E-01	-2.000	ECHS1,ECI1,HADHB,MCEE	
Tight Junction Signaling	1.39E00	8.89E-02	NaN	ACTB,ACTG1,BET1L,CLDN5,F11R,FOS,JUN,NAPA,OCLN,PPP2CB,PRKAG1,RHOA,VAMP3,VAPA,VASP,VTI1B	
Activation of NMDA receptors and postsynaptic events	1.38E00	1.07E-01	-3.000	CAMK1,HRAS,MAPK3,PRKAB1,PRKAG1,TUBA1A,TUBA1B,TUBB2A,TUBB4B	
PEDF Signaling	1.38E00	1.07E-01	-1.890	FAS,HRAS,MAPK3,NFKBIA,PNPLA2,RAP1A,RASD1,RHOA,RRAS	
iNOS Signaling	1.36E00	1.28E-01	-2.000	Calm1 (includes others),FOS,IFNGR1,IRF1,JUN,NFKBIA	
L1CAM interactions	1.36E00	9.6E-02	-3.464	ACTB,ACTG1,AP2A2,CLTA,CSNK2B,DPYSL2,HSPA8,MAPK3,TUBA1A,TUBA1B,TUBB2A,TUBB4B	
Glioma Signaling	1.36E00	9.6E-02	-2.646	Calm1 (includes others),CAMK1,CDKN1A,CDKN2B,CDKN2D,HRAS,IDH3G,MAPK3,PDGFB,RAP1A,RASD1,RRAS	
Synaptogenesis Signaling Pathway	1.35E00	7.94E-02	-3.545	AP2A2,APOE,ARPC1A,ARPC4,ARPC5L,BAD,BET1L,Calm1 (includes others),CFL1,CREB3,EFNA1,HRAS,HSPA8,MAPK3,NAPA,PRKAG1,RAB5A,RAP1A,RASD1,RASGRP2,RHOA,RRAS,SGTA,VAMP3,VTI1B	
Gαi Signaling	1.34E00	9.29E-02	-1.265	GNA11,GNAS,GNB2,GNG11,GNG5,HRAS,MAPK3,PRKAG1,RAP1A,RASD1,RGS12,RRAS,S1PR1	
Insulin Receptor Signaling	1.34E00	9.29E-02	-1.155	BAD,EIF2B4,EIF4E,GSK3A,HRAS,INPP5K,MAPK3,PPP1R11,PRKAG1,RAP1A,RASD1,RRAS,SGK1	
Cholesterol biosynthesis	1.33E00	1.6E-01	-2.000	EBP,FDPS,MSMO1,PLPP6	
Incretin synthesis, secretion, and inactivation	1.33E00	1.6E-01	-2.000	DPP4,SEC11A,SPCS1,SPCS2	
Response of EIF2AK1 (HRI) to heme deficiency	1.33E00	2E-01	NaN	ATF3,EIF2S2,PPP1R15A	
Endometrial Cancer Signaling	1.33E00	1.17E-01	-1.633	BAD,HRAS,ILK,MAPK3,RAP1A,RASD1,RRAS	
Oxidative Stress Induced Senescence	1.32E00	1.05E-01	-3.000	CDKN2B,CDKN2D,EZH2,FOS,JUN,MAPK3,RBBP4,RNF2,UBC	
Amyloid fiber formation	1.32E00	1.1E-01	-2.828	APOE,CST3,ITM2B,PSENEN,SIAH1,TTR,UBC,UBE2L6	
MyD88-independent TLR4 cascade	1.29E00	1.35E-01	-2.236	IRF7,UBC,UBE2D3,UBE2N,UBE2V1	
Noradrenaline and Adrenaline Degradation	1.29E00	1.35E-01	-2.236	ADH5,AKR1A1,ALDH2,COMT,SMOX	
Glioblastoma Multiforme Signaling	1.29E00	8.77E-02	-1.941	Cdc42,CDKN1A,CDKN1B,HRAS,MAPK3,NOTUM,PDGFB,RAP1A,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,TCF3	
TP53 Regulates Transcription of Cell Cycle Genes	1.29E00	1.22E-01	-2.449	CDKN1A,CDKN1B,CNOT3,CNOT8,PRMT1,RGCC	
ERK/MAPK Signaling	1.28E00	8.37E-02	-1.807	BAD,CREB3,DUSP1,EIF4E,FOS,H3-3A/H3-3B,HRAS,HSPB1,MAPK3,MKNK2,PPP1R11,PPP2CB,PRKAG1,RAP1A,RASD1,RRAS,YWHAH,YWHAQ	
RAR Activation	1.28E00	7.46E-02	-3.536	ACTB,Cdc42,CDKN1A,CDKN1B,CDKN2B,CREB3,CSNK2B,DUSP1,F11R,FOS,GDE1,GNA11,JUN,KLF2,MAPK3,NR2F6,PDE2A,PRDM16,PRKAG1,PRMT1,RARG,RBP1,RDH14,RHOA,RHOB,RHOC,RHOG,SMARCB1,SMPDL3A,TNFSF12,TNFSF13,ZBTB16	
CDK5 Signaling	1.28E00	9.57E-02	-1.897	CABLES1,FOSB,GNAS,HRAS,MAPK3,PPP1R11,PPP2CB,PRKAG1,RAP1A,RASD1,RRAS	
Xenobiotic Metabolism General Signaling Pathway	1.28E00	9.09E-02	-3.464	FTL,GSTK1,GSTM2,GSTM5,GSTT2/GSTT2B,HRAS,MAP3K8,MAPK3,NFE2L2,NR1H2,RAP1A,RASD1,RRAS	
Erythrocytes take up oxygen and release carbon dioxide	1.27E00	2.86E-01	NaN	CA2,CA4	
TYSND1 cleaves peroxisomal proteins	1.27E00	2.86E-01	NaN	ACAA1,SCP2	
Ceramide Biosynthesis	1.27E00	2.86E-01	NaN	DEGS2,SPTSSA	
Aspartate Degradation II	1.27E00	2.86E-01	NaN	MDH1,MDH2	
G Beta Gamma Signaling	1.27E00	9.3E-02	-3.162	CAV2,GNA11,GNAS,GNB2,GNG11,GNG5,HRAS,MAPK3,PRKAG1,RAP1A,RASD1,RRAS	
Cytoprotection by HMOX1	1.27E00	1.13E-01	-2.646	COX19,COX5A,COX7A2L,NFE2L2,STAP2,SURF1,TXNIP	
SUMOylation of DNA methylation proteins	1.26E00	1.88E-01	NaN	RNF2,SUMO1,UBE2I	
Acyl Carrier Protein Metabolism	1.26E00	1E00	NaN	AASDHPPT	
Glutamate Removal from Folates	1.26E00	1E00	NaN	GGH	
Phosphatidylethanolamine Biosynthesis III	1.26E00	1E00	NaN	PTDSS2	
Plasma lipoprotein assembly, remodeling, and clearance	1.24E00	1.05E-01	-2.828	ABCG1,AP2A2,APOE,CLTA,NR1H2,PLTP,SAR1B,UBC	
SUMOylation of DNA damage response and repair proteins	1.24E00	1.05E-01	-2.828	CETN2,NSMCE3,NSMCE4A,RNF2,SEC13,SUMO1,SUMO2,UBE2I	
GDNF Family Ligand-Receptor Interactions	1.24E00	1.05E-01	-2.646	DOK4,FOS,HRAS,JUN,MAPK3,RAP1A,RASD1,RRAS	
Macropinocytosis Signaling	1.24E00	1.05E-01	-2.000	ARF6,HRAS,PDGFB,RAB5A,RAP1A,RASD1,RHOA,RRAS	
Thrombopoietin Signaling	1.24E00	1.11E-01	-2.449	FOS,HRAS,JUN,MAPK3,RAP1A,RASD1,RRAS	
WNT/β-catenin Signaling	1.23E00	8.62E-02	0.000	CSNK1E,CSNK2B,GSK3A,ILK,JUN,PIN1,PPP2CB,RARG,SOX17,SOX18,SOX7,TCF3,Tcf7,Ubb,UBC	
PAK Signaling	1.23E00	9.4E-02	-2.828	CFL1,CFL2,HRAS,MAPK3,MYL11,MYL12A,MYL12B,PDGFB,RAP1A,RASD1,RRAS	
ATF4 activates genes in response to endoplasmic reticulum stress	1.23E00	1.48E-01	0.000	ATF3,EXOSC1,EXOSC8,HERPUD1	
Apelin Liver Signaling Pathway	1.23E00	1.48E-01	-2.000	EDN1,EDN3,FAS,GSK3A	
Mouse Embryonic Stem Cell Pluripotency	1.21E00	9.62E-02	-3.000	HRAS,ID1,ID2,ID3,MAPK3,RAP1A,RASD1,RRAS,TCF3,Tcf7	
Semaphorin interactions	1.21E00	1.09E-01	-2.646	CFL1,DPYSL2,MYL12B,RHOA,RHOB,RHOC,RRAS	
Myelination Signaling Pathway	1.2E00	7.65E-02	-3.000	ACVRL1,AKT1S1,ARF6,Calm1 (includes others),CREB3,EIF4E,FOS,HRAS,ID2,ILK,JUN,MAPK3,NDRG1,PDGFB,PLP1,PRKAG1,PSENEN,RAP1A,RASD1,RHEB,RHOA,RRAS,SLC2A1,XAF1,ZNF24	
GNRH Signaling	1.19E00	8.38E-02	-3.606	Calm1 (includes others),CREB3,FOS,GNA11,GNAS,GNB2,GNG11,GNG5,HRAS,JUN,MAP3K8,MAPK3,PRKAG1,RAP1A,RASD1,RRAS	
Gα12/13 Signaling	1.19E00	9.02E-02	-3.162	HRAS,JUN,LPAR6,MAPK3,MYL11,MYL12A,MYL12B,NFKBIA,RAP1A,RASD1,RHOA,RRAS	
UVB-Induced MAPK Signaling	1.18E00	1.15E-01	-2.236	BAD,EIF4E,FOS,H3-3A/H3-3B,JUN,MAPK3	
SUMOylation of intracellular receptors	1.18E00	1.43E-01	-2.000	NR1H2,SUMO1,SUMO2,UBE2I	
NFE2L2 regulates pentose phosphate pathway genes	1.17E00	2.5E-01	NaN	NFE2L2,TALDO1	
Senescence Pathway	1.16E00	7.69E-02	-2.236	ANAPC10,ANAPC11,ANAPC13,ATF3,Calm1 (includes others),CDKN1A,CDKN1B,CDKN2B,EIF4E,EZH2,GADD45G,HRAS,JUN,MAPK3,PDHB,PHF1,PPP2CB,RAP1A,RASD1,RNF2,RRAS,SQSTM1,YPEL3	
IL-3 Signaling	1.16E00	1.01E-01	-1.890	BAD,FOS,HRAS,JUN,MAPK3,RAP1A,RASD1,RRAS	
Post-translational protein phosphorylation	1.15E00	9.35E-02	-3.162	APOE,CCN1,CST3,GAS6,NOTUM,PDIA6,PNPLA2,PRSS23,SPARCL1,VWA1	
RNA Polymerase III Transcription	1.13E00	1.22E-01	-2.236	POLR1D,POLR2E,POLR2K,POLR3GL,SNAPC5	
Superpathway of Geranylgeranyldiphosphate Biosynthesis I (via Mevalonate)	1.13E00	1.67E-01	NaN	FDPS,HADHB,PMVK	
Prolactin Signaling	1.1E00	9.47E-02	-2.121	FOS,HRAS,IRF1,JUN,MAPK3,RAP1A,RASD1,RRAS,SOCS2	
Formation of WDR5-containing histone-modifying complexes	1.1E00	1.19E-01	-2.236	AKAP8L,BOD1,DPY30,MCRS1,TADA3	
April Mediated Signaling	1.1E00	1.19E-01	-1.342	FOS,JUN,NFKBIA,TNFSF13,TRAF5	
Sertoli Cell-Sertoli Cell Junction Signaling	1.09E00	7.82E-02	-4.359	ACTB,ACTG1,CLDN5,CREB3,F11R,HRAS,JUN,JUP,MAP3K8,MAPK3,OCLN,RAP1A,RASD1,RRAS,TUBA1A,TUBA1B,TUBB,TUBB2A,TUBB4B	
Signaling by CSF3 (G-CSF)	1.09E00	1.33E-01	-2.000	ELOC,RNF7,UBC,UBE2D3	
Metabolism of non-coding RNA	1.09E00	1.09E-01	-2.449	GEMIN7,NCBP2,PHAX,SEC13,SMN1/SMN2,SNRPB	
FLT3 Signaling in Hematopoietic Progenitor Cells	1.08E00	9.76E-02	-1.890	BAD,CREB3,EIF4E,HRAS,MAPK3,RAP1A,RASD1,RRAS	
Estrogen-Dependent Breast Cancer Signaling	1.08E00	9.76E-02	-2.646	CREB3,FOS,HRAS,JUN,MAPK3,RAP1A,RASD1,RRAS	
IL-1 Signaling	1.08E00	9.38E-02	-2.236	FOS,GNA11,GNAS,GNB2,GNG11,GNG5,JUN,NFKBIA,PRKAG1	
TGF-β Signaling	1.08E00	9.38E-02	-1.414	FOS,HRAS,IRF7,JUN,MAPK3,PMEPA1,RAP1A,RASD1,RRAS	
IL-10 Signaling	1.07E00	8.44E-02	-0.277	CDKN1A,CDKN2D,CREB3,DUSP1,FOS,HLA-A,HLA-E,IFNGR1,IL10RB,JUN,NFKBIA,PRKAB1,PRKAG1	
Adrenomedullin signaling pathway	1.07E00	8.04E-02	-3.207	BAD,Calm1 (includes others),FOS,GNA11,GNAS,GSK3A,HRAS,MAPK3,MAX,NOTUM,NT5C,PRKAG1,RAMP2,RAP1A,RASD1,RRAS	
Sleep REM Signaling Pathway	1.06E00	9.01E-02	-0.632	CFL1,CFL2,CREB3,EIF4E,FOS,MAPK3,Mt1,PRKAG1,TNFSF12,TNFSF13	
Oncostatin M Signaling	1.06E00	1.16E-01	-2.000	HRAS,MAPK3,RAP1A,RASD1,RRAS	
Folate Signaling Pathway	1.06E00	1.07E-01	-2.449	CDKN1A,CDKN1B,GGH,KLF4,MAPK3,MAT2A	
MyD88 dependent cascade initiated on endosome	1.05E00	1.29E-01	-2.000	IRF7,UBC,UBE2N,UBE2V1	
Chronic Myeloid Leukemia Signaling	1.04E00	7.55E-02	-1.964	AKT1S1,BAD,Calm1 (includes others),CDKN1A,CDKN1B,FAS,FOS,HES1,HRAS,JUN,KLF4,MAPK3,MCL1,NOTUM,PRKAB1,PRKAG1,RAP1A,RASD1,RRAS,TCF3,Tcf7	
Melanocyte Development and Pigmentation Signaling	1.04E00	9.18E-02	-2.828	CREB3,GNAS,HRAS,MAPK3,POMC,PRKAG1,RAP1A,RASD1,RRAS	
DNA Methylation and Transcriptional Repression Signaling	1.04E00	9.18E-02	-2.646	CDK11A,CDK8,CDK9,GADD45G,MBD3,RBBP4,SAP18,TCF15,TCF3	
UVA-Induced MAPK Signaling	1.04E00	9.18E-02	-2.236	FOS,HRAS,JUN,MAPK3,NOTUM,RAP1A,RASD1,RRAS,SMPD2	
Pulmonary Fibrosis Idiopathic Signaling Pathway	1.03E00	7.36E-02	-3.838	ACTB,ACTG1,CCN2,CXCL12,EDN1,EZH2,FOS,HES1,HRAS,ILK,JUN,MAPK3,PDGFB,PEX13,PINK1,RAP1A,RASD1,RBBP4,RHOA,RRAS,STK38,TCF3,Tcf7,VIM	
CD27 Signaling in Lymphocytes	1.03E00	1.05E-01	NaN	CYC1,FOS,JUN,MAP3K8,NFKBIA,TRAF5	
SUMOylation of transcription cofactors	1.03E00	1.14E-01	-2.236	DDX5,RNF2,SUMO1,SUMO2,UBE2I	
TAK1-dependent IKK and NF-kappa-B activation	1.03E00	1.14E-01	-2.236	NFKBIA,UBC,UBE2N,UBE2V1,USP18	
TP53 Regulates Transcription of Cell Death Genes	1.03E00	1.14E-01	-2.236	BNIP3L,CASP6,FAS,NDRG1,TRIAP1	
LPS-stimulated MAPK Signaling	1.01E00	9.41E-02	-2.646	FOS,HRAS,JUN,MAPK3,NFKBIA,RAP1A,RASD1,RRAS	
G-protein beta:gamma signalling	1.01E00	1.25E-01	-2.000	GNB2,GNG11,GNG5,RHOA	
Prostate Cancer Signaling	1E00	8.77E-02	NaN	BAD,CDKN1A,CDKN1B,CREB3,HRAS,MAPK3,NFKBIA,RAP1A,RASD1,RRAS	
Cancer Drug Resistance by Drug Efflux	1E00	1.03E-01	-2.449	ABCG2,HRAS,MAPK3,RAP1A,RASD1,RRAS	
IL-6 Signaling	9.97E-01	8.53E-02	-2.530	CSNK2B,FOS,HRAS,HSPB1,JUN,MAPK3,MCL1,NFKBIA,RAP1A,RASD1,RRAS	
Carboxyterminal post-translational modifications of tubulin	9.97E-01	1.11E-01	-2.236	TPGS1,TUBA1A,TUBA1B,TUBB2A,TUBB4B	
p75 NTR receptor-mediated signalling	9.96E-01	9E-02	-3.000	ARHGDIA,BAD,NFKBIA,PSENEN,RHOA,SMPD2,SQSTM1,UBC,YWHAE	
Macrophage Classical Activation Signaling Pathway	9.96E-01	7.94E-02	-1.155	CD40,EZH2,GBP2,GBP4,IFNAR2,IFNGR1,IRF1,NFKBIA,PDHB,RBBP4,SDHB,SDHD,STK38,TNFSF12,TNFSF13	
Neurotransmitter clearance	9.91E-01	2E-01	NaN	ALDH2,COMT	
RHOBTB3 ATPase cycle	9.91E-01	2E-01	NaN	PLIN3,RAB9A	
Signaling by ERBB4	9.75E-01	1.02E-01	-2.449	APOE,CXCL12,HRAS,PSENEN,STMN1,UBC	
DNA Double Strand Break Response	9.75E-01	1.02E-01	-2.449	PPP5C,SUMO1,UBC,UBE2I,UBE2N,UBE2V2	
Xenobiotic Metabolism AHR Signaling Pathway	9.7E-01	9.2E-02	-1.414	ABCG2,ALDH2,ANKRA2,GSTK1,GSTM2,GSTM5,GSTT2/GSTT2B,SUMO1	
Lipoate Biosynthesis and Incorporation II	9.69E-01	5E-01	NaN	LIAS	
L-DOPA Degradation	9.69E-01	5E-01	NaN	COMT	
Xanthine and Xanthosine Salvage	9.69E-01	5E-01	NaN	PNP	
Thyroid Hormone Biosynthesis	9.69E-01	5E-01	NaN	CTSD	
Glycine Degradation (Creatine Biosynthesis)	9.69E-01	5E-01	NaN	GATM	
Cardiolipin Biosynthesis II	9.69E-01	5E-01	NaN	PTPMT1	
tRNA Splicing	9.66E-01	1.09E-01	-2.236	GDE1,PDE2A,SMPDL3A,TSEN15,TSEN34	
Regulation of the Epithelial Mesenchymal Transition by Growth Factors Pathway	9.54E-01	7.81E-02	-2.840	FOS,HRAS,ID2,JUN,MAPK3,OCLN,PDGFB,RAP1A,RASD1,RHOA,RRAS,TCF3,TNFSF12,TNFSF13,VIM	
Synaptic Long Term Potentiation	9.46E-01	8.33E-02	-2.530	Calm1 (includes others),CREB3,GNA11,HRAS,MAPK3,NOTUM,PPP1R11,PRKAG1,RAP1A,RASD1,RRAS	
Response to elevated platelet cytosolic Ca2+	9.46E-01	8.33E-02	-3.317	ALDOA,APOOL,CFL1,GAS6,GTPBP2,MANF,PDGFB,SELENOP,TEX264,VTI1B,WDR1	
Integration of energy metabolism	9.38E-01	8.74E-02	-2.449	GNA11,GNAS,GNB2,GNG11,GNG5,PPP2CB,RAP1A,SLC2A1,TALDO1	
SUMOylation of SUMOylation proteins	9.37E-01	1.18E-01	-2.000	SEC13,SUMO1,SUMO2,UBE2I	
Putrescine Degradation III	9.26E-01	1.36E-01	NaN	ALDH2,SAT1,SMOX	
Tumor Microenvironment Pathway	9.21E-01	7.82E-02	-1.604	BAD,CXCL12,FAS,FOS,HLA-A,HLA-E,HRAS,JUN,MAPK3,PDGFB,RAP1A,RASD1,RRAS,SLC2A1	
Erythrocytes take up carbon dioxide and release oxygen	9.2E-01	1.82E-01	NaN	CA2,CA4	
RHO GTPases activate KTN1	9.2E-01	1.82E-01	NaN	RHOA,RHOG	
Ketogenesis	9.2E-01	1.82E-01	NaN	HADHB,HMGCL	
XBP1(S) activates chaperone genes	9.07E-01	1.04E-01	-2.236	ATP6V0D1,DNAJB9,GSK3A,MYDGF,PDIA6	
Retinol Biosynthesis	9.07E-01	1.04E-01	-2.000	DHRS7,ESD,PNPLA2,RBP1,RDH14	
NGF Signaling	8.97E-01	8.33E-02	-3.000	CREB3,HRAS,MAP3K8,MAPK3,RAP1A,RASD1,RHOA,RHOG,RRAS,SMPD2	
BMP signaling pathway	8.88E-01	8.79E-02	-2.449	ACVRL1,HRAS,JUN,MAPK3,PRKAG1,RAP1A,RASD1,RRAS	
Actin Cytoskeleton Signaling	8.87E-01	7.38E-02	-3.000	ACTB,ACTG1,ARPC1A,ARPC4,ARPC5L,BAIAP2,CFL1,CFL2,HRAS,MAPK3,MYL11,MYL12A,MYL12B,PDGFB,RAP1A,RASD1,RHOA,RRAS	
NAD Signaling Pathway	8.84E-01	7.95E-02	-2.646	LDHA,PDGFB,POLR2C,POLR2D,POLR2E,POLR2I,POLR2K,PRKAB1,PRKAG1,SIRT2,SIRT7,SLC7A5	
RAF-independent MAPK1/3 activation	8.83E-01	1.3E-01	NaN	DUSP1,DUSP7,MAPK3	
Apelin Cardiac Fibroblast Signaling Pathway	8.83E-01	1.3E-01	NaN	CCN2,PRKAB1,PRKAG1	
D-myo-inositol (1,4,5,6)-Tetrakisphosphate Biosynthesis	8.8E-01	7.69E-02	-3.162	ALPL,ATP1A2,DUSP1,DUSP11,ILKAP,MDP1,NOCT,NT5C,NUDT14,NUDT9,PLPP6,PPP1R11,PPP2CB,PPP5C	
D-myo-inositol (3,4,5,6)-tetrakisphosphate Biosynthesis	8.8E-01	7.69E-02	-3.162	ALPL,ATP1A2,DUSP1,DUSP11,ILKAP,MDP1,NOCT,NT5C,NUDT14,NUDT9,PLPP6,PPP1R11,PPP2CB,PPP5C	
D-myo-inositol-5-phosphate Metabolism	8.74E-01	7.58E-02	-3.317	ALPL,ATP1A2,DUSP1,DUSP11,ILKAP,MDP1,NOCT,NT5C,NUDT14,NUDT9,PIP4P1,PLPP6,PPP1R11,PPP2CB,PPP5C	
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	8.69E-01	1.11E-01	-1.000	APOE,CDKN1A,SUMO1,UBE2I	
FLT3 Signaling	8.69E-01	1.11E-01	-2.000	CDKN1B,HRAS,SOCS2,UBC	
DHCR24 Signaling Pathway	8.65E-01	8.03E-02	-3.317	APOD,APOE,HRAS,NR1H2,PDGFB,PLTP,POMC,RAP1A,RASD1,RRAS,TTR	
PPAR Signaling	8.64E-01	8.41E-02	2.828	FOS,HRAS,JUN,MAPK3,NFKBIA,PDGFB,RAP1A,RASD1,RRAS	
Xenobiotic Metabolism Signaling	8.63E-01	7.14E-02	NaN	ALDH2,ANKRA2,CAMK1,ESD,FMO2,FTL,GSTK1,GSTM2,GSTM5,GSTT2/GSTT2B,HRAS,HS3ST1,MAP3K8,MAPK3,NFE2L2,PPP2CB,RAP1A,RASD1,RRAS,SMOX,SUMO1	
IL-7 Signaling Pathway	8.58E-01	8.97E-02	0.378	BAD,CDKN1B,GSK3A,JUN,MAPK3,MCL1,SLC2A1	
Vitamin D (calciferol) metabolism	8.56E-01	1.67E-01	NaN	SUMO2,UBE2I	
Tryptophan catabolism	8.56E-01	1.67E-01	NaN	SLC3A2,SLC7A5	
Signaling by EGFR	8.53E-01	1E-01	-2.236	AAMP,HRAS,SH3GL1,SPRY1,UBC	
NR1H2 and NR1H3-mediated signaling	8.53E-01	1E-01	-2.236	ABCG1,APOD,APOE,NR1H2,PLTP	
MYC Mediated Apoptosis Signaling	8.53E-01	1E-01	-1.342	ADRB2,FAS,MAX,MCL1,PRKAG1	
Regulation of TP53 Activity through Phosphorylation	8.5E-01	8.6E-02	-2.828	CSNK2B,PIN1,PRKAB1,PRKAG1,RPA3,TAF11,TAF7,UBC	
Adrenergic Receptor Signaling Pathway (Enhanced)	8.49E-01	7.5E-02	-2.840	ADRB2,ATP6V0B,ATP6V0C,ATP6V0D1,ATP6V0E1,ATP6V1F,ATP6V1G1,COMT,DDC,GNAS,NOTUM,PRKAG1,SMOX,TNFSF12,TNFSF13	
Signaling by VEGF	8.47E-01	8.33E-02	-3.000	AAMP,ACTB,ACTG1,BAIAP2,HRAS,HSPB1,JUP,PRR5L,RHOA	
Sulfur amino acid metabolism	8.42E-01	1.25E-01	NaN	ETHE1,SQOR,TXN2	
The Visual Cycle	8.42E-01	1.25E-01	NaN	DHRS7,RBP1,RDH14	
Methionine Degradation I (to Homocysteine)	8.42E-01	1.25E-01	NaN	MAT2A,MAT2B,PRMT1	
Acute Phase Response Signaling	8.4E-01	7.57E-02	-1.732	FOS,FTL,HNRNPK,HRAS,JUN,MAPK3,NFKBIA,RAP1A,RASD1,RBP1,RRAS,SOCS2,TCF3,TTR	
Detoxification of Reactive Oxygen Species	8.38E-01	1.08E-01	-2.000	GPX1,PRDX3,PRDX6,TXN2	
Gαq Signaling	8.33E-01	7.65E-02	-3.162	Calm1 (includes others),Cdc42,GNA11,GNAS,GNB2,GNG11,GNG5,MAPK3,NFKBIA,RHOA,RHOB,RHOC,RHOG	
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by IGFBPs	8.31E-01	8.06E-02	-3.162	APOE,CCN1,CST3,GAS6,NOTUM,PDIA6,PNPLA2,PRSS23,SPARCL1,VWA1	
RAB geranylgeranylation	8.29E-01	9.23E-02	-2.449	RAB11B,RAB18,RAB24,RAB4A,RAB5A,RAB9A	
Amyloid Processing	8.27E-01	9.8E-02	NaN	CSNK1E,CSNK2B,MAPK3,PRKAG1,PSENEN	
Cell Cycle: G2/M DNA Damage Checkpoint Regulation	8.27E-01	9.8E-02	NaN	CDKN1A,PTPMT1,YWHAE,YWHAH,YWHAQ	
Activin Inhibin Signaling Pathway	8.22E-01	7.34E-02	-1.500	BAMBI,CCN2,CDKN1A,CDKN1B,FOS,FOSB,JUN,MAPK3,MAX,NFKBIA,PMEPA1,PNPLA2,RHOA,SKIL,SOX17,TCF3	
PIP3 activates AKT signaling	8.2E-01	7.86E-02	-3.317	AKT1S1,BAD,CDKN1A,CDKN1B,GSK3A,MAPK3,MKRN1,PDGFB,PPP2CB,PRR5L,RHOG	
Dopamine Receptor Signaling	8.17E-01	8.75E-02	NaN	COMT,DDC,PPP1R11,PPP2CB,PRKAG1,SMOX,SPR	
FXR/RXR Activation	8.15E-01	7.49E-02	-2.138	APOE,GCLM,GSTK1,GSTM2,GSTM5,GSTT2/GSTT2B,Mt1,NFE2L2,PLTP,PRKAB1,PRKAG1,TNFSF12,TNFSF13,TXNIP	
Interleukin-4 and Interleukin-13 signaling	8.13E-01	8.18E-02	-3.000	CDKN1A,FOS,HSPA8,JUNB,MCL1,PIM1,POMC,S1PR1,VIM	
Cell Cycle Regulation by BTG Family Proteins	8.07E-01	1.05E-01	NaN	BTG1,NOCT,PPP2CB,PRMT1	
Notch Signaling	8.07E-01	1.05E-01	NaN	HES1,LFNG,MFNG,PSENEN	
Lactose synthesis	8.05E-01	3.33E-01	NaN	SLC2A1	
MTF1 activates gene expression	8.05E-01	3.33E-01	NaN	CSRP1	
NFE2L2 regulating TCA cycle genes	8.05E-01	3.33E-01	NaN	NFE2L2	
Regulation of NFE2L2 gene expression	8.05E-01	3.33E-01	NaN	NFE2L2	
NADH Repair	8.05E-01	3.33E-01	NaN	NAXD	
Methylglyoxal Degradation I	8.05E-01	3.33E-01	NaN	HAGH	
Guanine and Guanosine Salvage I	8.05E-01	3.33E-01	NaN	PNP	
Glutathione Biosynthesis	8.05E-01	3.33E-01	NaN	GCLM	
Tetrahydrobiopterin Biosynthesis I	8.05E-01	3.33E-01	NaN	SPR	
Hypusine Biosynthesis	8.05E-01	3.33E-01	NaN	EIF5A	
Adenine and Adenosine Salvage I	8.05E-01	3.33E-01	NaN	PNP	
Tetrahydrobiopterin Biosynthesis II	8.05E-01	3.33E-01	NaN	SPR	
N-acetylglucosamine Degradation I	8.05E-01	3.33E-01	NaN	GNPDA2	
MyD88 cascade initiated on plasma membrane	8.03E-01	1.2E-01	NaN	UBC,UBE2N,UBE2V1	
Apoptotic execution phase	8.01E-01	9.62E-02	-2.236	CASP6,FNTA,HMGB2,OCLN,VIM	
Gαs Signaling	8E-01	7.94E-02	-2.828	ADRB2,CREB3,GNA11,GNAS,GNB2,GNG11,GNG5,MAPK3,PRKAG1,RAP1A	
Assembly of RNA Polymerase I Complex	7.99E-01	1.54E-01	NaN	POLR1D,UBTF	
Cholesterol Biosynthesis I	7.99E-01	1.54E-01	NaN	EBP,MSMO1	
Cholesterol Biosynthesis II (via 24,25-dihydrolanosterol)	7.99E-01	1.54E-01	NaN	EBP,MSMO1	
Guanosine Nucleotides Degradation III	7.99E-01	1.54E-01	NaN	NT5C,PNP	
Cholesterol Biosynthesis III (via Desmosterol)	7.99E-01	1.54E-01	NaN	EBP,MSMO1	
Death Receptor Signaling	7.95E-01	8.33E-02	-1.134	ACTB,ACTG1,CASP6,CYC1,FAS,HSPB1,NFKBIA,TNFSF12	
Netrin Signaling	7.93E-01	7.51E-02	-1.941	ARPC1A,ARPC4,ARPC5L,BET1L,DPYSL2,FMO2,MAPK3,NAPA,PRKAG1,RHOA,VAMP3,VASP,VTI1B	
Neutrophil Extracellular Trap Signaling Pathway	7.86E-01	6.75E-02	-4.811	CASP6,CYC1,MAPK3,MCL1,NDUFA3,NDUFA6,NDUFA7,NDUFB10,NDUFB11,NDUFS2,NDUFS3,NOTUM,PNPLA2,PPID,PRDX6,SDHB,SDHD,SLC2A1,TIMM17A,TOMM20,TOMM22,TOMM6,TOMM7,UQCRFS1,VDAC1,VDAC2,VDAC3	
Phase II - Conjugation of compounds	7.85E-01	8.96E-02	-2.449	ABHD14B,COMT,ESD,MAT2A,MAT2B,TRMT112	
CD40 Signaling	7.85E-01	8.96E-02	-1.633	CD40,FOS,JUN,MAPK3,NFKBIA,TRAF5	
RHO GTPase cycle	7.83E-01	6.67E-02	-5.477	ACTB,ACTG1,AKAP12,ARFGAP2,ARHGDIA,BAIAP2,CDC42EP1,COPS4,DDRGK1,DDX39B,EMC3,FERMT2,GPS1,JUP,LAMTOR1,MTX1,NDUFS3,NUDC,RHOA,RHOB,RHOC,RHOG,STIP1,STK38,TFRC,TMEM59,TRA2B,TUBA1B,VAMP3,VIM	
MAP kinase activation	7.79E-01	1.03E-01	-2.000	MAP3K8,UBC,UBE2N,UBE2V1	
Regulation of TP53 Expression and Degradation	7.79E-01	1.03E-01	-2.000	PPP2CB,PRR5L,SGK1,UBC	
Superpathway of Methionine Degradation	7.79E-01	1.03E-01	-2.000	MAT2A,MAT2B,MCEE,PRMT1	
Antigen Presentation Pathway	7.79E-01	1.03E-01	NaN	HLA-A,HLA-E,PSMB9,TAP2	
Orexin Signaling Pathway	7.76E-01	7.14E-02	-4.123	AKT1S1,ATP6V0B,ATP6V0C,ATP6V0D1,ATP6V0E1,ATP6V1F,ATP6V1G1,Calm1 (includes others),GNAS,GNB2,GNG11,GNG5,MAPK3,NOTUM,PRDM16,PRKAB1,PRKAG1	
IL-17A Signaling in Gastric Cells	7.67E-01	1.15E-01	NaN	FOS,JUN,MAPK3	
Cysteine Biosynthesis III (mammalia)	7.67E-01	1.15E-01	NaN	MAT2A,MAT2B,PRMT1	
Role of Tissue Factor in Cancer	7.65E-01	7.25E-02	-3.357	CCN1,CCN2,CFL1,CFL2,EIF4E,FOS,GNA11,HRAS,JUN,MAPK3,PDIA6,PPP2CB,RAP1A,RASD1,RRAS	
ERBB4 Signaling	7.64E-01	8.82E-02	-2.000	HRAS,MAPK3,PSENEN,RAP1A,RASD1,RRAS	
Signaling by FGFR3	7.51E-01	1E-01	-2.000	HRAS,MAPK3,PPP2CB,UBC	
Transcriptional Regulation by VENTX	7.51E-01	1E-01	-2.000	ANAPC10,ANAPC11,ANAPC16,UBE2S	
Urate Biosynthesis/Inosine 5'-phosphate Degradation	7.47E-01	1.43E-01	NaN	NT5C,PNP	
Mevalonate Pathway I	7.47E-01	1.43E-01	NaN	HADHB,PMVK	
Phenylalanine Degradation IV (Mammalian, via Side Chain)	7.47E-01	1.43E-01	NaN	ALDH2,SMOX	
Cell Cycle: G1/S Checkpoint Regulation	7.44E-01	8.7E-02	-1.633	CDKN1A,CDKN1B,CDKN2B,CDKN2D,MAX,RPL11	
SPINK1 General Cancer Pathway	7.44E-01	8.7E-02	-1.342	HRAS,MAPK3,Mt1,RAP1A,RASD1,RRAS	
Role of MAPK Signaling in the Pathogenesis of Influenza	7.42E-01	8.33E-02	NaN	HRAS,MAPK3,PNPLA2,PRDX6,RAP1A,RASD1,RRAS	
AMPK Signaling	7.34E-01	7.02E-02	-1.265	ACTB,ADRB2,AKT1S1,CDKN1A,CREB3,GNA11,GNAS,GNB2,GNG11,GNG5,ILKAP,MLYCD,PPP2CB,PRKAB1,PRKAG1,SLC2A1,SMARCB1	
Pyroptosis	7.33E-01	1.11E-01	NaN	CHMP2B,CHMP6,IRF1	
Glycolysis I	7.33E-01	1.11E-01	NaN	ALDOA,ENO1,PGAM1	
Signaling by PTK6	7.31E-01	9.09E-02	-2.236	CDKN1B,HRAS,RHOA,STAP2,UBC	
PPARα/RXRα Activation	7.31E-01	7.22E-02	0.000	ACAA1,AP2A2,GNA11,GNAS,HRAS,JUN,MAPK3,NFKBIA,NOTUM,PRKAB1,PRKAG1,RAP1A,RASD1,RRAS	
Endothelin-1 Signaling	7.31E-01	7.22E-02	-3.317	CASP6,EDN1,FOS,GNA11,GNAS,HRAS,JUN,MAPK3,NOTUM,PNPLA2,PRDX6,RAP1A,RASD1,RRAS	
ATM Signaling	7.28E-01	8E-02	0.000	CBX1,CBX3,CDKN1A,CREB3,GADD45G,JUN,NFKBIA,PPP2CB	
Gamma carboxylation, hypusine formation and arylsulfatase activation	7.24E-01	9.76E-02	-2.000	DPH3,EIF5A,GAS6,TPST2	
Signaling by FGFR4	7.24E-01	9.76E-02	-2.000	HRAS,MAPK3,PPP2CB,UBC	
GM-CSF Signaling	7.24E-01	8.57E-02	-2.000	HRAS,MAPK3,PIM1,RAP1A,RASD1,RRAS	
CSDE1 Signaling Pathway	7.09E-01	8.93E-02	-2.236	CDK11A,FOS,PABPC4,RPL9,VIM	
NLR signaling pathways	7.09E-01	8.93E-02	-2.236	AAMP,TXNIP,UBC,UBE2N,UBE2V1	
SUMOylation of chromatin organization proteins	7.09E-01	8.93E-02	-2.236	RNF2,SEC13,SUMO1,SUMO2,UBE2I	
Cell Cycle Control of Chromosomal Replication	7.09E-01	8.93E-02	-2.236	CDK11A,CDK8,CDK9,ORC6,RPA3	
EGF Signaling	7.09E-01	8.93E-02	-2.236	CSNK2B,FOS,HRAS,JUN,MAPK3	
Platelet homeostasis	7.07E-01	8.14E-02	-2.646	GNAS,GNB2,GNG11,GNG5,PDE2A,PPP2CB,SRI	
Signaling by Activin	7E-01	1.33E-01	NaN	DRAP1,MAPK3	
Metabolism of nitric oxide: NOS3 activation and regulation	7E-01	1.33E-01	NaN	DDAH2,SPR	
Mismatch Repair	7E-01	1.33E-01	NaN	POLD4,RPA3	
Retinoate Biosynthesis II	6.92E-01	2.5E-01	NaN	RBP1	
Heme Biosynthesis from Uroporphyrinogen-III I	6.92E-01	2.5E-01	NaN	UROD	
Catecholamine Biosynthesis	6.92E-01	2.5E-01	NaN	DDC	
Phenylethylamine Degradation I	6.92E-01	2.5E-01	NaN	ALDH2	
Methylmalonyl Pathway	6.92E-01	2.5E-01	NaN	MCEE	
D-glucuronate Degradation I	6.92E-01	2.5E-01	NaN	AKR1A1	
Proline Biosynthesis I	6.92E-01	2.5E-01	NaN	PYCR2	
Melatonin Degradation II	6.92E-01	2.5E-01	NaN	SMOX	
Rapoport-Luebering Glycolytic Shunt	6.92E-01	2.5E-01	NaN	PGAM1	
Molybdenum Cofactor Biosynthesis	6.92E-01	2.5E-01	NaN	MOCS2	
Fatty Acid β-oxidation III (Unsaturated, Odd Number)	6.92E-01	2.5E-01	NaN	ECI1	
Sphingolipid metabolism	6.9E-01	8.05E-02	-2.646	CERS2,DEGS2,ORMDL2,ORMDL3,SMPD2,SPTSSA,VAPA	
HIPPO signaling	6.9E-01	8.05E-02	1.342	CSNK1E,PPP1R11,PPP2CB,RASSF1,YWHAE,YWHAH,YWHAQ	
CNTF Signaling	6.88E-01	8.77E-02	-2.000	HRAS,MAPK3,RAP1A,RASD1,RRAS	
Pancreatic Secretion Signaling Pathway	6.85E-01	6.88E-02	-3.638	AKT1S1,ARHGDIA,BET1L,CA14,CA2,CA4,GNAS,MAPK3,NAPA,NOTUM,PPP1R11,PRKAG1,RAP1A,RHOA,SLC6A6,VAMP3,VTI1B	
Cellular Effects of Sildenafil (Viagra)	6.84E-01	7.33E-02	NaN	ACTB,ACTG1,Calm1 (includes others),GNAS,MYL11,MYL12A,MYL12B,NOTUM,PABPC4,PDE2A,PRKAG1	
Pulmonary Healing Signaling Pathway	6.76E-01	7.04E-02	-2.673	ACKR3,CFL1,CFL2,CXCL12,HRAS,MAPK3,NFKBIA,PRKAB1,PRKAG1,RAP1A,RASD1,RRAS,TCF3,Tcf7	
MSP-RON Signaling in Macrophages Pathway	6.75E-01	7.56E-02	-2.333	CREB3,FOS,HRAS,IFNGR1,JUN,MAPK3,RAP1A,RASD1,RRAS	
Vasopressin regulates renal water homeostasis via Aquaporins	6.74E-01	9.3E-02	-2.000	GNAS,GNB2,GNG11,GNG5	
Smooth Muscle Contraction	6.74E-01	9.3E-02	-2.000	ALDH2,MYL11,MYL12A,MYL12B	
Assembly and cell surface presentation of NMDA receptors	6.74E-01	9.3E-02	-2.000	TUBA1A,TUBA1B,TUBB2A,TUBB4B	
B Cell Activating Factor Signaling	6.74E-01	9.3E-02	NaN	FOS,JUN,NFKBIA,TRAF5	
Ion channel transport	6.73E-01	7.1E-02	-3.464	ATP1A2,ATP6V0B,ATP6V0C,ATP6V0D1,ATP6V0E1,ATP6V1F,ATP6V1G1,CLCN4,SGK1,SRI,TSC22D3,TTYH2,UBC	
STAT3 Pathway	6.73E-01	7.41E-02	-1.890	CDKN1A,HRAS,IL10RB,MAPK3,PDGFB,PIM1,RAP1A,RASD1,RRAS,SOCS2	
Serotonin Degradation	6.68E-01	8.22E-02	-2.449	ADH5,AKR1A1,ALDH2,B3GAT3,B4GAT1,SMOX	
Oxytocin Signaling Pathway	6.66E-01	6.74E-02	-4.359	Calm1 (includes others),CREB3,FOS,GNA11,GNB2,GNG11,GNG5,HRAS,HSPB1,MAPK3,NFE2L2,NT5C,PNPLA2,PRKAB1,PRKAG1,RAP1A,RASD1,RHOA,RRAS	
Corticotropin Releasing Hormone Signaling	6.6E-01	7.24E-02	-2.828	Calm1 (includes others),CREB3,FOS,GNAS,JUN,JUND,MAPK3,NT5C,POMC,PRKAG1,RAP1A	
Rap1 signalling	6.58E-01	1.25E-01	NaN	RAP1A,RASGRP2	
D-myo-inositol (1,4,5)-trisphosphate Degradation	6.58E-01	1.25E-01	NaN	INPP1,INPP5K	
Adenosine Nucleotides Degradation II	6.58E-01	1.25E-01	NaN	NT5C,PNP	
MIF Regulation of Innate Immunity	6.5E-01	9.09E-02	-2.000	FOS,JUN,MAPK3,NFKBIA	
Metabolism of water-soluble vitamins and cofactors	6.47E-01	8.47E-02	-2.236	AASDHPPT,CD320,ENPP2,MOCS2,SLC2A1	
IL-12 Signaling and Production in Macrophages	6.42E-01	6.81E-02	1.000	APOD,APOE,Calm1 (includes others),CD40,FOS,H3-3A/H3-3B,IFNGR1,IL10RB,IRF1,JMJD6,JUN,MAP3K8,MAPK3,PRKAB1,PRKAG1,ZIC2	
Activation of kainate receptors upon glutamate binding	6.41E-01	1E-01	NaN	GNB2,GNG11,GNG5	
Immunogenic Cell Death Signaling Pathway	6.41E-01	7.78E-02	-2.646	ATG5,DAPK3,HSPA1A/HSPA1B,Hspa1b,HSPA8,IFNAR2,IFNGR1	
Superpathway of Inositol Phosphate Compounds	6.33E-01	6.78E-02	-3.464	ALPL,ATP1A2,DUSP1,DUSP11,ILKAP,INPP5K,MDP1,NOCT,NT5C,NUDT14,NUDT9,PIP4P1,PLPP6,PPP1R11,PPP2CB,PPP5C	
Caveolar-mediated Endocytosis Signaling	6.33E-01	8E-02	NaN	ACTB,ACTG1,COPZ1,HLA-A,HLA-E,RAB5A	
SUMOylation of DNA replication proteins	6.28E-01	8.89E-02	-2.000	SEC13,SUMO1,SUMO2,UBE2I	
GPER1 signaling	6.28E-01	8.89E-02	-2.000	GNAS,GNB2,GNG11,GNG5	
Visual phototransduction	6.28E-01	8.33E-02	-2.236	FNTA,NMT1,NMT2,RBP1,TTR	
Crosstalk between Dendritic Cells and Natural Killer Cells	6.26E-01	7.69E-02	NaN	ACTB,ACTG1,CD40,CD83,FAS,HLA-A,HLA-E	
RANK Signaling in Osteoclasts	6.26E-01	7.69E-02	-2.449	Calm1 (includes others),FOS,JUN,MAP3K8,MAPK3,NFKBIA,TRAF5	
Necroptosis Signaling Pathway	6.24E-01	7.1E-02	-3.317	FAS,PPID,TIMM17A,TOMM20,TOMM22,TOMM6,TOMM7,UBC,VDAC1,VDAC2,VDAC3	
Paxillin Signaling	6.22E-01	7.48E-02	-2.646	ACTB,ACTG1,ARF1,ARF6,HRAS,RAP1A,RASD1,RRAS	
Adipogenesis pathway	6.22E-01	7.19E-02	0.632	ACVRL1,ATG5,EZH2,NOCT,RBBP4,RBP1,SAP18,SAP30L,SIRT2,TXNIP	
Isoleucine Degradation I	6.18E-01	1.18E-01	NaN	ECHS1,HADHB	
Angiopoietin Signaling	6.16E-01	7.89E-02	-0.447	BAD,HRAS,NFKBIA,RAP1A,RASD1,RRAS	
Aldosterone Signaling in Epithelial Cells	6.16E-01	6.98E-02	NaN	DNAJA1,DNAJB1,DNAJB9,DNAJC30,DUSP1,HSPA12B,HSPA1A/HSPA1B,HSPA8,HSPB1,MAPK3,NOTUM,SGK1	
Cristae formation	6.14E-01	9.68E-02	NaN	APOOL,MTX1,TMEM11	
Multiple Sclerosis Signaling Pathway	6.09E-01	6.76E-02	-2.840	DUSP1,EZH2,FAS,GAS5,HLA-A,HLA-E,IFNGR1,IRF1,MAPK3,MGAT1,PLP1,RBBP4,STK38,TNFSF12,TNFSF13	
Telomerase Signaling	6.09E-01	7.41E-02	-1.342	CDKN1A,HRAS,MAPK3,PPP2CB,RAP1A,RASD1,RRAS,TERF2IP	
Formation of xylulose-5-phosphate	6.07E-01	2E-01	NaN	AKR1A1	
FasL/ CD95L signaling	6.07E-01	2E-01	NaN	FAS	
Formation of lateral plate mesoderm	6.07E-01	2E-01	NaN	FOXF1	
Arsenate Detoxification I (Glutaredoxin)	6.07E-01	2E-01	NaN	PNP	
Proline Biosynthesis II (from Arginine)	6.07E-01	2E-01	NaN	PYCR2	
CMP-N-acetylneuraminate Biosynthesis I (Eukaryotes)	6.07E-01	2E-01	NaN	NAGK	
Lysine Degradation II	6.07E-01	2E-01	NaN	AASDHPPT	
Myo-inositol Biosynthesis	6.07E-01	2E-01	NaN	ISYNA1	
Lysine Degradation V	6.07E-01	2E-01	NaN	AASDHPPT	
2-oxobutanoate Degradation I	6.07E-01	2E-01	NaN	MCEE	
Trans, trans-farnesyl Diphosphate Biosynthesis	6.07E-01	2E-01	NaN	FDPS	
DNA damage-induced 14-3-3σ Signaling	6.06E-01	8.7E-02	-2.000	BAD,CASP6,CDKN1A,CDKN1B	
Macrophage Alternative Activation Signaling Pathway	5.99E-01	6.84E-02	-1.941	AKT1S1,CREB3,DUSP1,FOS,H3-3A/H3-3B,IL10RB,JUN,KLF4,LAMTOR1,MAPK3,NFKBIA,NR1H2,TSC22D3	
ERBB Signaling	5.96E-01	7.53E-02	-2.449	FOS,HRAS,JUN,MAPK3,RAP1A,RASD1,RRAS	
RIPK1-mediated regulated necrosis	5.88E-01	9.38E-02	NaN	FAS,STUB1,UBC	
TNFR2 Signaling	5.88E-01	9.38E-02	NaN	FOS,JUN,NFKBIA	
Dopamine Degradation	5.88E-01	9.38E-02	NaN	ALDH2,COMT,SMOX	
3-phosphoinositide Biosynthesis	5.85E-01	6.73E-02	-3.162	ALPL,ATP1A2,DUSP1,DUSP11,ILKAP,MDP1,NOCT,NT5C,NUDT14,NUDT9,PLPP6,PPP1R11,PPP2CB,PPP5C	
Ephrin A Signaling	5.85E-01	8.51E-02	NaN	CFL1,CFL2,EFNA1,RHOA	
Signaling by NOTCH1	5.84E-01	7.69E-02	-2.449	CCNC,CDK8,HES1,PSENEN,TLE5,UBC	
VDR/RXR Activation	5.84E-01	7.69E-02	NaN	CCNC,CDKN1A,CDKN1B,GTF2B,HES1,KLF4	
NF-κB Activation by Viruses	5.84E-01	7.69E-02	-2.236	HRAS,MAPK3,NFKBIA,RAP1A,RASD1,RRAS	
Unfolded Protein Response (UPR)	5.82E-01	1.11E-01	NaN	CREB3,EIF2S2	
Branched-chain amino acid catabolism	5.82E-01	1.11E-01	NaN	BCKDK,ECHS1	
Gastrin-CREB signalling pathway via PKC and MAPK	5.82E-01	1.11E-01	NaN	HRAS,MAPK3	
Kinetochore Metaphase Signaling Pathway	5.82E-01	7.27E-02	0.000	ANAPC10,ANAPC11,ANAPC13,ARPP19,BOD1,BUB3,MAD2L2,PPP1R11	
Pyroptosis Signaling Pathway	5.82E-01	7.45E-02	-1.134	GAS5,GBP2,GBP4,GBP5,PRKAG1,RHOA,TXNIP	
Non-Small Cell Lung Cancer Signaling	5.82E-01	7.45E-02	-1.633	BAD,HRAS,MAPK3,RAP1A,RASD1,RASSF1,RRAS	
Signaling by MET	5.68E-01	7.59E-02	-2.449	ARF6,HRAS,RAB4A,RAP1A,SH3GL1,UBC	
Role of JAK family kinases in IL-6-type Cytokine Signaling	5.68E-01	7.59E-02	-2.449	FOS,IRF1,JUNB,MAPK3,MCL1,POMC	
Gene Silencing by RNA	5.68E-01	7.37E-02	-2.646	POLR2C,POLR2D,POLR2E,POLR2I,POLR2K,PRKRA,SEC13	
G alpha (z) signalling events	5.65E-01	8.33E-02	-2.000	GNAS,GNB2,GNG11,GNG5	
IL-27 Signaling Pathway	5.6E-01	7.03E-02	-2.333	CD40,GADD45G,HLA-A,HLA-E,IFNAR2,IFNGR1,IRF1,LPAR6,MCL1	
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)	5.56E-01	7.14E-02	-2.828	POLD4,RPA3,SEM1,SUMO2,UBC,UBE2I,UBE2N,UBE2V2	
G alpha (12/13) signalling events	5.53E-01	7.5E-02	-2.449	GNB2,GNG11,GNG5,RHOA,RHOB,RHOC	
Glucose metabolism	5.53E-01	7.5E-02	-2.449	ALDOA,GNPDA2,MDH1,MDH2,PPP2CB,SEC13	
Metabolism of cofactors	5.49E-01	1.05E-01	NaN	COQ5,SPR	
FOXO-mediated transcription	5.49E-01	1.05E-01	NaN	TXNIP,YWHAQ	
NFE2L2 regulating anti-oxidant/detoxification enzymes	5.49E-01	1.05E-01	NaN	GCLM,NFE2L2	
Purine Nucleotides Degradation II (Aerobic)	5.49E-01	1.05E-01	NaN	NT5C,PNP	
PFKFB4 Signaling Pathway	5.45E-01	8.16E-02	NaN	CREB3,GNAS,MAPK3,PRKAG1	
Creatine metabolism	5.4E-01	1.67E-01	NaN	GATM	
Pyruvate Fermentation to Lactate	5.4E-01	1.67E-01	NaN	LDHA	
Serotonin and Melatonin Biosynthesis	5.4E-01	1.67E-01	NaN	DDC	
Pentose Phosphate Pathway (Non-oxidative Branch)	5.4E-01	1.67E-01	NaN	TALDO1	
Zymosterol Biosynthesis	5.4E-01	1.67E-01	NaN	MSMO1	
Pyridoxal 5'-phosphate Salvage Pathway	5.39E-01	7.69E-02	-2.000	CDK8,MAP3K8,MAPK3,PIM1,SGK1	
Signaling by NOTCH2	5.39E-01	8.82E-02	NaN	HES1,PSENEN,UBC	
4-1BB Signaling in T Lymphocytes	5.39E-01	8.82E-02	NaN	JUN,MAPK3,NFKBIA	
HOTAIR Regulatory Pathway	5.38E-01	6.75E-02	-1.265	CDKN1A,EZH2,H3-3A/H3-3B,IRF1,NFKBIA,RBBP4,RHOC,STK38,TCF3,Tcf7,VIM	
Cardiac β-adrenergic Signaling	5.35E-01	6.67E-02	-1.134	AKAP12,GDE1,GNA11,GNAS,GNB2,GNG11,GNG5,PDE2A,PPP1R11,PPP2CB,PRKAG1,SMPDL3A	
p53 Signaling	5.27E-01	7.14E-02	-1.342	CASP6,CDKN1A,FAS,GADD45G,JUN,SERPINE2,ST13	
Signaling by ERBB2	5.27E-01	8E-02	-2.000	HRAS,RHOA,STUB1,UBC	
Signaling by FGFR1	5.27E-01	8E-02	-2.000	HRAS,MAPK3,PPP2CB,UBC	
PI Metabolism	5.24E-01	7.32E-02	-2.449	ARF1,GDE1,INPP5K,PIP4P1,RAB4A,RAB5A	
Natural Killer Cell Signaling	5.23E-01	6.57E-02	-1.387	CFL1,CFL2,HLA-A,HLA-E,HRAS,HSPA1A/HSPA1B,Hspa1b,HSPA8,MAP3K8,MAPK3,RAP1A,RASD1,RRAS	
Signaling by Hippo	5.18E-01	1E-01	NaN	AMOTL2,YWHAE	
Valine Degradation I	5.18E-01	1E-01	NaN	ECHS1,HADHB	
GPVI-mediated activation cascade	5.17E-01	8.57E-02	NaN	RHOA,RHOB,RHOG	
PRC2 methylates histones and DNA	5.17E-01	8.57E-02	NaN	EZH2,PHF1,RBBP4	
Ethanol Degradation II	5.17E-01	8.57E-02	NaN	ADH5,AKR1A1,ALDH2	
HGF Signaling	5.15E-01	6.82E-02	-2.121	CDKN1A,FOS,HRAS,JUN,MAP3K8,MAPK3,RAP1A,RASD1,RRAS	
GABA Receptor Signaling	5.15E-01	6.82E-02	NaN	AP2A2,GABARAP,GNA11,GNAS,GNB2,GNG11,GNG5,Ubb,UBC	
Oxytocin in Brain Signaling Pathway	5.14E-01	6.53E-02	-3.464	Calm1 (includes others),CREB3,GNA11,GNB2,GNG11,GNG5,HRAS,MAPK3,PNPLA2,PRDX6,RAP1A,RASD1,RRAS	
Docosahexaenoic Acid (DHA) Signaling	5.13E-01	6.4E-02	-1.291	AKT1S1,BAD,CREB3,FAS,GNAS,GSK3A,MAPK3,MFSD2A,NFE2L2,NOTUM,PDGFB,PNPLA2,PRDX6,PRKAB1,PRKAG1,PSENEN	
Transport of bile salts and organic acids, metal ions and amine compounds	5.1E-01	7.23E-02	-2.449	BSG,SLC22A8,SLC31A1,SLC39A8,SLC40A1,SLC6A6	
TNFR1 Signaling	5.08E-01	7.84E-02	-2.000	CASP6,FOS,JUN,NFKBIA	
ID1 Signaling Pathway	4.97E-01	6.47E-02	-1.941	ACVRL1,ATF3,CCN2,CDKN1A,CDKN1B,HRAS,ID1,MAPK3,RAP1A,RASD1,RHOC,RRAS,VIM	
VEGF Family Ligand-Receptor Interactions	4.97E-01	7.14E-02	-2.236	FOS,HRAS,MAPK3,RAP1A,RASD1,RRAS	
B-WICH complex positively regulates rRNA expression	4.91E-01	7.69E-02	-2.000	ACTB,POLR1D,POLR2E,POLR2K	
cAMP-mediated signaling	4.89E-01	6.36E-02	-2.138	ADRB2,AKAP12,Calm1 (includes others),CAMK1,CREB3,CREM,DUSP1,GDE1,GNAS,MAPK3,PDE2A,RAP1A,RGS12,S1PR1,SMPDL3A	
Pentose phosphate pathway	4.84E-01	1.43E-01	NaN	TALDO1	
Epithelial-Mesenchymal Transition (EMT) during gastrulation	4.84E-01	1.43E-01	NaN	OCLN	
Arginine Degradation VI (Arginase 2 Pathway)	4.84E-01	1.43E-01	NaN	PYCR2	
Acetyl-CoA Biosynthesis I (Pyruvate Dehydrogenase Complex)	4.84E-01	1.43E-01	NaN	PDHB	
Adenine and Adenosine Salvage III	4.84E-01	1.43E-01	NaN	PNP	
Glycoaminoglycan-protein Linkage Region Biosynthesis	4.84E-01	1.43E-01	NaN	B3GAT3	
Sensory processing of sound by inner hair cells of the cochlea	4.78E-01	7.25E-02	-2.236	ACTB,ACTG1,CAPZA2,TRIOBP,TWF2	
Role of JAK1 and JAK3 in γc Cytokine Signaling	4.78E-01	7.25E-02	NaN	HRAS,MAPK3,RAP1A,RASD1,RRAS	
Beta-catenin independent WNT signaling	4.78E-01	6.86E-02	-2.646	AP2A2,CLTA,GNB2,GNG11,GNG5,RHOA,UBC	
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	4.75E-01	8.11E-02	NaN	CBX3,MBD3,RBBP4	
TWEAK Signaling	4.75E-01	8.11E-02	NaN	CASP6,NFKBIA,TNFSF12	
Role of Hypercytokinemia/hyperchemokinemia in the Pathogenesis of Influenza	4.71E-01	6.98E-02	-1.633	IFIT3,IFNAR2,IRF7,ISG15,RSAD2,S1PR1	
Cellular hexose transport	4.63E-01	9.09E-02	NaN	SLC2A1,SLC50A1	
Peroxisomal lipid metabolism	4.63E-01	9.09E-02	NaN	SCP2,SLC25A17	
RHO GTPases Activate NADPH Oxidases	4.63E-01	9.09E-02	NaN	MAPK3,PIN1	
Superpathway of D-myo-inositol (1,4,5)-trisphosphate Metabolism	4.63E-01	9.09E-02	NaN	INPP1,INPP5K	
Ribonucleotide Reductase Signaling Pathway	4.62E-01	6.43E-02	-2.111	ACTB,AKT1S1,BAD,CDKN1A,CREB3,EIF4E,FOS,H3-3A/H3-3B,JUN,MAPK3,SMARCB1	
IL-17A Signaling in Fibroblasts	4.58E-01	6.9E-02	-2.449	CXCL12,FOS,JUN,MAPK3,NFKBIA,P4HA2	
SUMOylation of ubiquitinylation proteins	4.55E-01	7.89E-02	NaN	SEC13,SUMO1,UBE2I	
Transport of inorganic cations/anions and amino acids/oligopeptides	4.55E-01	6.73E-02	-2.646	SLC38A2,SLC38A3,SLC38A5,SLC3A2,SLC6A6,SLC7A5,SRI	
NOD1/2 Signaling Pathway	4.55E-01	6.35E-02	-2.887	FOS,HSPA1A/HSPA1B,Hspa1b,HSPA8,IFNAR2,IRF7,JUN,MAP3K8,MAPK3,NFKBIA,TNFSF12,TNFSF13	
Renin-Angiotensin Signaling	4.53E-01	6.61E-02	-2.646	FOS,HRAS,JUN,MAPK3,PRKAG1,RAP1A,RASD1,RRAS	
Reelin Signaling in Neurons	4.53E-01	6.52E-02	-2.121	APOE,ARPC1A,ARPC4,ARPC5L,CFL1,MAPK3,NDEL1,RAP1A,RHOA	
Sensory processing of sound by outer hair cells of the cochlea	4.43E-01	7.27E-02	-2.000	ACTB,ACTG1,TRIOBP,TWF2	
Lymphotoxin β Receptor Signaling	4.43E-01	7.27E-02	NaN	CYC1,MAPK3,NFKBIA,TRAF5	
Signaling by NODAL	4.38E-01	8.7E-02	NaN	DRAP1,MAPK3	
Surfactant metabolism	4.38E-01	8.7E-02	NaN	CCDC59,CTSH	
Role of Lipids/Lipid Rafts in the Pathogenesis of Influenza	4.38E-01	8.7E-02	NaN	FDPS,RSAD2	
Vitamin-C Transport	4.38E-01	8.7E-02	NaN	LRRC8A,SLC2A1	
Purine Ribonucleosides Degradation to Ribose-1-phosphate	4.38E-01	1.25E-01	NaN	PNP	
Sphingomyelin Metabolism	4.38E-01	1.25E-01	NaN	SMPD2	
DNA Damage/Telomere Stress Induced Senescence	4.27E-01	7.14E-02	-2.000	ASF1A,CDKN1A,CDKN1B,TERF2IP	
Triacylglycerol Biosynthesis	4.27E-01	7.14E-02	NaN	ELOVL1,PLPP5,PLPP6,SIRT2	
Opioid Signalling	4.22E-01	6.67E-02	-2.449	GNA11,GNB2,GNG11,GNG5,POMC,PPP2CB	
Regulation of Cellular Mechanics by Calpain Protease	4.22E-01	6.67E-02	-2.236	CDKN1B,HRAS,MAPK3,RAP1A,RASD1,RRAS	
Erythropoietin Signaling Pathway	4.2E-01	6.25E-02	-0.905	BAD,FOS,HRAS,JUN,MAPK3,NFKBIA,RAP1A,RASD1,RRAS,TNFSF12,TNFSF13	
Other interleukin signaling	4.14E-01	8.33E-02	NaN	IL10RB,STX3	
Growth hormone receptor signaling	4.14E-01	8.33E-02	NaN	MAPK3,SOCS2	
IL-22 Signaling	4.14E-01	8.33E-02	NaN	IL10RB,MAPK3	
Tumoricidal Function of Hepatic Natural Killer Cells	4.14E-01	8.33E-02	NaN	CASP6,FAS	
TNF signaling	4.13E-01	7.02E-02	-2.000	SMPD2,STUB1,UBC,UBE2D3	
Triacylglycerol Degradation	3.99E-01	6.9E-02	NaN	ALDH2,NOTUM,PNPLA2,PRDX6	
GPCR-Mediated Integration of Enteroendocrine Signaling Exemplified by an L Cell	3.99E-01	6.67E-02	-0.447	ADRB2,GNA11,GNAS,NOTUM,PRKAG1	
Abacavir ADME	3.98E-01	1.11E-01	NaN	ABCG2	
Sucrose Degradation V (Mammalian)	3.98E-01	1.11E-01	NaN	ALDOA	
Leucine Degradation I	3.98E-01	1.11E-01	NaN	HMGCL	
Insulin processing	3.93E-01	8E-02	NaN	CPE,EXOC7	
MyD88:MAL(TIRAP) cascade initiated on plasma membrane	3.86E-01	7.14E-02	NaN	UBC,UBE2N,UBE2V1	
Circadian Clock	3.85E-01	6.78E-02	NaN	CREM,CSNK1E,PER1,UBC	
Synaptic Long Term Depression	3.85E-01	6.06E-02	-2.121	GNA11,GNAS,HRAS,MAPK3,NOTUM,NT5C,PNPLA2,PPP2CB,PRDX6,RAP1A,RASD1,RRAS	
PCP (Planar Cell Polarity) Pathway	3.72E-01	6.67E-02	-2.000	JUN,JUNB,JUND,RHOA	
WNT ligand biogenesis and trafficking	3.72E-01	7.69E-02	NaN	SNX3,VPS29	
Role of JAK1, JAK2 and TYK2 in Interferon Signaling	3.72E-01	7.69E-02	NaN	IFNAR2,IFNGR1	
Estrogen-mediated S-phase Entry	3.72E-01	7.69E-02	NaN	CDKN1A,CDKN1B	
Role of WNT/GSK-3β Signaling in the Pathogenesis of Influenza	3.64E-01	6.41E-02	NaN	CSNK1E,NCOA4,SIAH1,TCF3,Tcf7	
Toll-like Receptor Signaling	3.64E-01	6.41E-02	NaN	FOS,JUN,NFKBIA,Ubb,UBC	
Human Embryonic Stem Cell Pluripotency	3.64E-01	5.97E-02	-2.887	ACVRL1,HRAS,ID1,ID2,ID3,KLF2,KLF4,PDGFB,RAP1A,RASD1,RRAS,TCF3	
POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	3.63E-01	1E-01	NaN	TSC22D1	
Caspase activation via Dependence Receptors in the absence of ligand	3.63E-01	1E-01	NaN	DAPK3	
Ketone body metabolism	3.63E-01	1E-01	NaN	HMGCL	
Ketolysis	3.63E-01	1E-01	NaN	HADHB	
Kinesins	3.6E-01	6.56E-02	-2.000	TUBA1A,TUBA1B,TUBB2A,TUBB4B	
Class B/2 (Secretin family receptors)	3.59E-01	6.25E-02	-2.449	ADGRE5,GNAS,GNB2,GNG11,GNG5,RAMP2	
Small Cell Lung Cancer Signaling	3.59E-01	6.25E-02	NaN	CDKN1B,CDKN2B,CYC1,MAX,NFKBIA,TRAF5	
Signaling by Retinoic Acid	3.56E-01	6.82E-02	NaN	PDHB,RARG,RDH14	
Retinoid metabolism and transport	3.56E-01	6.82E-02	NaN	APOE,RBP1,TTR	
Role of MAPK Signaling in Inhibiting the Pathogenesis of Influenza	3.53E-01	6.33E-02	NaN	JUN,MAPK3,NFKBIA,PNPLA2,PRDX6	
Integrin signaling	3.53E-01	7.41E-02	NaN	RAP1A,RASGRP2	
Dilated Cardiomyopathy Signaling Pathway	3.49E-01	6E-02	-1.134	ACTB,ACTG1,BAD,CAMK1,GNAS,ILK,MAPK3,PDE2A,PRKAG1	
Semaphorin Neuronal Repulsive Signaling Pathway	3.49E-01	6E-02	0.333	CFL1,CFL2,DPYSL2,MYL11,MYL12A,MYL12B,PRKAG1,RHOA,RRAS	
Salvage Pathways of Pyrimidine Ribonucleotides	3.49E-01	6.19E-02	-2.236	CDK8,CMPK2,MAP3K8,MAPK3,PIM1,SGK1	
LPS/IL-1 Mediated Inhibition of RXR Function	3.47E-01	5.84E-02	1.342	ABCG1,ALAS1,ALDH2,APOE,Cyp2d22,FMO2,GSTK1,GSTM2,GSTM5,GSTT2/GSTT2B,HS3ST1,JUN,NR1H2,PLTP,SMOX	
Atherosclerosis Signaling	3.43E-01	6.02E-02	NaN	APOD,APOE,CD40,CXCL12,PDGFB,PNPLA2,PRDX6,TNFSF12	
Arachidonic acid metabolism	3.41E-01	6.67E-02	NaN	GPX1,GPX4,PON2	
Bladder Cancer Signaling	3.37E-01	6.03E-02	-2.000	CDKN1A,HRAS,MAPK3,RAP1A,RASD1,RASSF1,RRAS	
Glyoxylate metabolism and glycine degradation	3.35E-01	7.14E-02	NaN	LIAS,PDHB	
Alpha-protein kinase 1 signaling pathway	3.33E-01	9.09E-02	NaN	UBC	
Pentose Phosphate Pathway	3.33E-01	9.09E-02	NaN	TALDO1	
Role of NFAT in Cardiac Hypertrophy	3.31E-01	5.8E-02	-3.317	Calm1 (includes others),CAMK1,GNAS,GNB2,GNG11,GNG5,HRAS,MAPK3,NOTUM,PRKAG1,RAP1A,RASD1,RRAS	
Apelin Cardiomyocyte Signaling Pathway	3.3E-01	6.06E-02	-2.449	GNA11,MAPK3,MYL11,MYL12A,MYL12B,NOTUM	
Neuregulin Signaling	3.29E-01	5.98E-02	-0.816	BAD,CDKN1B,HRAS,MAPK3,RAP1A,RASD1,RRAS	
Cytosolic sensors of pathogen-associated DNA	3.28E-01	6.52E-02	NaN	IRF7,NFKBIA,UBC	
Role of OCT4 in Mammalian Embryonic Stem Cell Pluripotency	3.28E-01	6.52E-02	NaN	CASP6,NR2F6,SH3GLB1	
SNARE Signaling Pathway	3.2E-01	5.88E-02	-2.828	BET1L,Calm1 (includes others),HSPA8,NAPA,PRKAG1,SGTA,VAMP3,VTI1B	
NAFLD Signaling Pathway	3.19E-01	5.75E-02	-1.387	AKT1S1,CASP6,FOS,GSK3A,JUN,NFE2L2,PNPLA2,PPP2CB,PRKAB1,PRKAG1,SOCS2,TNFSF12,TNFSF13	
Role of Osteoblasts in Rheumatoid Arthritis Signaling Pathway	3.19E-01	5.74E-02	-1.387	ACVRL1,ALPL,CSNK1E,CTSC,CTSD,CTSF,CTSH,CTSV,CXCL12,MAPK3,TCF3,Tcf7,TNFSF12,TNFSF13	
Processing of Capped Intronless Pre-mRNA	3.18E-01	6.9E-02	NaN	NCBP2,SNRPB	
Peptide hormone biosynthesis	3.06E-01	8.33E-02	NaN	POMC	
γ-glutamyl Cycle	3.06E-01	8.33E-02	NaN	GCLM	
Mineralocorticoid Biosynthesis	3.06E-01	8.33E-02	NaN	EBP	
eNOS Signaling	3.06E-01	5.77E-02	0.000	Calm1 (includes others),GNAS,HSPA1A/HSPA1B,Hspa1b,HSPA8,LPAR6,PRKAB1,PRKAG1,STUB1	
p38 MAPK Signaling	3.05E-01	5.83E-02	-1.890	CREB3,DUSP1,FAS,H3-3A/H3-3B,HSPB1,MAX,MKNK2	
Glutamate Receptor Signaling	3.03E-01	6.06E-02	NaN	Calm1 (includes others),GNB2,GNG11,GNG5	
Mitotic Prophase	2.96E-01	5.83E-02	-2.449	ARPP19,CNEP1R1,LEMD2,MAPK3,PPP2CB,SEC13	
Mitotic Roles of Polo-Like Kinase	2.93E-01	5.97E-02	NaN	ANAPC10,ANAPC11,ANAPC13,PPP2CB	
Ovarian Cancer Signaling	2.92E-01	5.7E-02	-2.449	EDN1,HRAS,MAPK3,PRKAG1,RAP1A,RASD1,RRAS,TCF3,Tcf7	
Neuroprotective Role of THOP1 in Alzheimer's Disease	2.9E-01	5.74E-02	-1.000	DPP4,HLA-A,HLA-E,HTRA1,PRKAG1,PRSS23,YWHAE	
Asparagine N-linked glycosylation	2.87E-01	6.45E-02	NaN	NAGK,NUDT14	
Methylglyoxal Degradation III	2.87E-01	6.45E-02	NaN	AKR1A1,DHRS7	
Cyclins and Cell Cycle Regulation	2.86E-01	5.81E-02	2.236	CDKN1A,CDKN1B,CDKN2B,CDKN2D,PPP2CB	
Trafficking and processing of endosomal TLR	2.82E-01	7.69E-02	NaN	CTSV	
Cytosolic iron-sulfur cluster assembly	2.82E-01	7.69E-02	NaN	CIAO1	
Transcriptional regulation of testis differentiation	2.82E-01	7.69E-02	NaN	FOXL2	
Glucocorticoid Biosynthesis	2.82E-01	7.69E-02	NaN	EBP	
UDP-N-acetyl-D-galactosamine Biosynthesis II	2.82E-01	7.69E-02	NaN	GNPDA2	
LXR/RXR Activation	2.82E-01	5.69E-02	-1.633	ABCG1,APOD,APOE,ECHS1,NR1H2,PLTP,TTR	
Signaling by NOTCH3	2.79E-01	6E-02	NaN	HES1,PSENEN,UBC	
FAT10 Cancer Signaling Pathway	2.79E-01	6E-02	NaN	ACKR3,MAD2L2,NFKBIA	
Glutaminergic Receptor Signaling Pathway (Enhanced)	2.77E-01	5.54E-02	-4.243	AKT1S1,BAD,BET1L,Calm1 (includes others),CREB3,EIF4E,GNAS,MAPK3,NAPA,NOTUM,PNPLA2,PRDX6,PRKAG1,SLC38A2,SLC38A3,SLC38A5,VAMP3,VTI1B	
WNK Renal Signaling Pathway	2.72E-01	5.66E-02	NaN	ANAPC10,ANAPC11,Calm1 (includes others),ELOC,LRRC8A,SGK1	
Transcriptional regulation by RUNX2	2.68E-01	5.88E-02	NaN	CDKN1A,HES1,MAPK3	
PD-1, PD-L1 cancer immunotherapy pathway	2.65E-01	5.61E-02	0.000	CDKN1B,CSNK2B,HLA-A,HLA-E,IFNGR1,PDCD4	
Glutamate and glutamine metabolism	2.61E-01	7.14E-02	NaN	PYCR2	
Aspirin ADME	2.61E-01	7.14E-02	NaN	BSG	
Acyl-CoA Hydrolysis	2.61E-01	7.14E-02	NaN	PPT1	
Activation of the pre-replicative complex	2.59E-01	6.06E-02	NaN	ORC6,RPA3	
Stearate Biosynthesis I (Animals)	2.55E-01	5.63E-02	NaN	DHRS7,ELOVL1,PPT1,SIRT2	
Heparan Sulfate Biosynthesis	2.53E-01	5.56E-02	-2.000	ALDH2,B3GAT3,HS3ST1,NOTUM,PRDX6	
Melatonin Signaling	2.46E-01	5.56E-02	-2.000	Calm1 (includes others),MAPK3,NOTUM,PRKAG1	
Regulation of cholesterol biosynthesis by SREBP (SREBF)	2.42E-01	6.67E-02	NaN	SAR1B	
YAP1- and WWTR1 (TAZ)-stimulated gene expression	2.42E-01	6.67E-02	NaN	CCN2	
Telomere Extension by Telomerase	2.42E-01	6.67E-02	NaN	TERF2IP	
Oxytocin in Spinal Neurons Signaling Pathway	2.34E-01	5.71E-02	NaN	GNA11,NT5C	
Metabolism of steroid hormones	2.34E-01	5.71E-02	NaN	POMC,STARD3NL	
Transcriptional Regulation by NPAS4	2.34E-01	5.71E-02	NaN	FOS,MAPK3	
Caspase activation via Death Receptors in the presence of ligand	2.24E-01	6.25E-02	NaN	FAS	
FOXO-mediated transcription of cell death genes	2.24E-01	6.25E-02	NaN	PINK1	
Chondroitin Sulfate Degradation (Metazoa)	2.24E-01	6.25E-02	NaN	HYAL2	
Glutaryl-CoA Degradation	2.24E-01	6.25E-02	NaN	HADHB	
Bile Acid Biosynthesis, Neutral Pathway	2.24E-01	6.25E-02	NaN	SCP2	
MIF-mediated Glucocorticoid Regulation	2.23E-01	5.56E-02	NaN	MAPK3,NFKBIA	
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	2.08E-01	5.88E-02	NaN	HRAS	
Transcriptional regulation of pluripotent stem cells	2.08E-01	5.88E-02	NaN	KLF4	
Protein methylation	2.08E-01	5.88E-02	NaN	HSPA8	
Signaling by NTRK3 (TRKC)	2.08E-01	5.88E-02	NaN	HRAS	
1D-myo-inositol Hexakisphosphate Biosynthesis II (Mammalian)	2.08E-01	5.88E-02	NaN	INPP5K	
Dermatan Sulfate Degradation (Metazoa)	2.08E-01	5.88E-02	NaN	HYAL2	
D-myo-inositol (1,3,4)-trisphosphate Biosynthesis	2.08E-01	5.88E-02	NaN	INPP5K	
Metabolism of Angiotensinogen to Angiotensins	1.94E-01	5.56E-02	NaN	CTSD	
Metabolism of amine-derived hormones	1.94E-01	5.56E-02	NaN	DDC	
Formation of definitive endoderm	1.94E-01	5.56E-02	NaN	SOX17	
Neurovascular Coupling Signaling Pathway	-0E00	2.59E-02	-1.342	Calm1 (includes others),NT5C,PNPLA2,PRDX6,PRKAG1,RHOA	
Wound Healing Signaling Pathway	-0E00	5.16E-02	-3.051	FOS,HRAS,IFNGR1,JUN,MAPK3,NFKBIA,PDGFB,RAP1A,RASD1,RRAS,TNFSF12,TNFSF13,VIM	
IL-13 Signaling Pathway	-0E00	3.45E-02	-2.000	DUSP1,JUN,MAPK3,RHOA	
CDX Gastrointestinal Cancer Signaling Pathway	-0E00	3.47E-02	1.134	FOS,JUN,MAPK3,TCF3,Tcf7,TNFSF12,TNFSF13	
Pathogen Induced Cytokine Storm Signaling Pathway	-0E00	3.23E-02	-3.464	CXCL12,FOS,FTL,IFNAR2,IFNGR1,IRF1,IRF7,JUN,MAPK3,SLC2A1,TNFSF12,TNFSF13	
Role of Chondrocytes in Rheumatoid Arthritis Signaling Pathway	-0E00	4.96E-02	-1.890	AKT1S1,CXCL12,FOS,JUN,MAPK3,PRKAB1,PRKAG1	
Role of Osteoclasts in Rheumatoid Arthritis Signaling Pathway	-0E00	5.52E-02	-3.638	BAD,Calm1 (includes others),Cdc42,CREB3,FOS,HRAS,JUN,MAPK3,NFKBIA,RAP1A,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,TRAF5	
S100 Family Signaling Pathway	-0E00	3.89E-02	-4.747	ACKR3,ADGRE5,ADRB2,BSG,CACYBP,Calm1 (includes others),CCRL2,CDKN1A,COPS5,CREB3,CTSD,FOS,GNA11,GPR4,IL10RB,ILK,JUN,LPAR6,MAP3K8,MAPK3,NOTUM,OCLN,PLAT,PRKAG1,RHOA,S1PR1,S1PR4,STK38,TCF3,Tcf7	
Leukocyte Extravasation Signaling	-0E00	4.15E-02	-1.890	ACTB,ACTG1,CLDN5,CXCL12,F11R,RAP1A,RHOA,VASP	
Amyotrophic Lateral Sclerosis Signaling	-0E00	1.72E-02	NaN	GPX1,RAB5A	
Fc Epsilon RI Signaling	-0E00	5.08E-02	-1.342	HRAS,INPP5K,MAPK3,RAP1A,RASD1,RRAS	
Chaperone Mediated Autophagy Signaling Pathway	-0E00	4.41E-02	-1.134	ATP6V0B,ATP6V0C,ATP6V0D1,ATP6V0E1,ATP6V1F,ATP6V1G1,DNAJB1,EIF4A1,EIF4H,GPX4,HSPA1A/HSPA1B,Hspa1b,HSPA8,MCL1,NFE2L2,NFKBIA,PLIN3,PRKAB1,PRKAG1,PRR5L,PSMA1,PSMA5,PSMA6,PSMB9,RAB11B,STIP1,STUB1,TPT1	
IL-33 Signaling Pathway	-0E00	4.86E-02	-1.667	CASP6,CREB3,FOS,ICAM2,JUN,MAP3K8,MAPK3,NFKBIA,PRKAG1	
Acetylcholine Receptor Signaling Pathway	-0E00	4.64E-02	-1.667	Calm1 (includes others),CASP6,CREB3,GNA11,MAPK3,NFE2L2,NOTUM,PRKAG1,PSENEN	
GABAergic Receptor Signaling Pathway (Enhanced)	-0E00	4.32E-02	-1.633	GNB2,GNG11,GNG5,PRKAG1,SLC38A2,SLC38A3	
NFKBIE Signaling Pathway	-0E00	8.91E-03	-1.000	CD40,NFKBIA,TNFSF12,TNFSF13	
G alpha (i) signalling events	-0E00	3.49E-02	-3.000	ACKR3,CXCL12,GNAS,GNB2,GNG11,GNG5,POMC,RGS12,S1PR4	
Neurotransmitter release cycle	-0E00	5E-02	NaN	ARL6IP5,SLC38A2	
Effects of PIP2 hydrolysis	-0E00	3.7E-02	NaN	RASGRP2	
Meiotic synapsis	-0E00	3.64E-02	NaN	TERF2IP,UBE2I	
Interleukin-7 signaling	-0E00	4.76E-02	NaN	SOCS2	
Potassium Channels	-0E00	3.88E-02	-2.000	GNB2,GNG11,GNG5,HCN2	
BMAL1:CLOCK,NPAS2 activates circadian gene expression	-0E00	3.7E-02	NaN	NOCT	
Formation of Fibrin Clot (Clotting Cascade)	-0E00	2.56E-02	NaN	SERPINE2	
Signaling by SCF-KIT	-0E00	4.65E-02	NaN	GRAP,HRAS	
Degradation of the extracellular matrix	-0E00	4.55E-02	NaN	BSG,CTSV,HTRA1	
Extracellular matrix organization	-0E00	2.83E-02	NaN	CEACAM1,PDGFB,TTR	
Glycerophospholipid biosynthesis	-0E00	5.05E-02	-2.236	CSNK2B,GPCPD1,HADHB,PNPLA2,PTDSS2	
Elastic fibre formation	-0E00	2.27E-02	NaN	LTBP4	
Telomere Maintenance	-0E00	4.11E-02	NaN	POLD4,RPA3,TERF2IP	
Mitochondrial biogenesis	-0E00	4.69E-02	NaN	ALAS1,PRKAB1,PRKAG1	
Activation of Matrix Metalloproteinases	-0E00	3.03E-02	NaN	CTSV	
Glycosaminoglycan metabolism	-0E00	5E-02	-2.000	B3GAT3,B3GNT2,B4GAT1,HYAL2	
Collagen biosynthesis and modifying enzymes	-0E00	4.48E-02	NaN	CRTAP,P4HA2,PPIB	
Regulation of beta-cell development	-0E00	2.38E-02	NaN	HES1	
Signaling by PDGF	-0E00	5.17E-02	NaN	HRAS,PDGFB,PLAT	
Pre-NOTCH Expression and Processing	-0E00	5.26E-02	-2.000	JUN,LFNG,MFNG,TMED2	
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	-0E00	1.98E-02	-2.000	CD40,HLA-A,HLA-E,ICAM2	
Signaling by BMP	-0E00	3.85E-02	NaN	ACVRL1	
Signaling by ALK	-0E00	3.57E-02	NaN	PTN	
Assembly of collagen fibrils and other multimeric structures	-0E00	3.28E-02	NaN	CD151,CTSV	
Cell surface interactions at the vascular wall	-0E00	3.79E-02	-2.828	BSG,CEACAM1,ESAM,F11R,GAS6,HRAS,SLC3A2,SLC7A5	
Fcgamma receptor (FCGR) dependent phagocytosis	-0E00	4.46E-02	-2.646	ACTB,ACTG1,ARPC1A,ARPC4,BAIAP2,CFL1,MAPK3	
Generic Transcription Pathway	-0E00	4.21E-02	-4.243	CCNC,CDK8,MED10,MED20,MED31,MED4,MED7,MED8,NR1H2,NR2F6,NRBF2,NRBP1,RARG,ZNF212,ZNF519,ZNF560,ZNF706,ZNF771	
Phase I - Functionalization of compounds	-0E00	3.92E-02	-2.000	ADH5,ALDH2,POMC,SMOX	
Integrin cell surface interactions	-0E00	3.53E-02	NaN	BSG,F11R,ICAM2	
DAP12 interactions	-0E00	4.76E-02	NaN	HLA-E,HRAS	
Binding and Uptake of Ligands by Scavenger Receptors	-0E00	1.79E-02	NaN	APOE,FTL	
Activation of gene expression by SREBF (SREBP)	-0E00	4.88E-02	NaN	FDPS,PMVK	
Syndecan interactions	-0E00	3.7E-02	NaN	TRAPPC4	
Class A/1 (Rhodopsin-like receptors)	-0E00	3.15E-02	-3.162	ACKR3,ADRB2,CCRL2,CXCL12,EDN1,EDN3,GPR4,LPAR6,POMC,S1PR1	
Netrin-1 signaling	-0E00	2E-02	NaN	SIAH1	
NCAM signaling for neurite out-growth	-0E00	3.28E-02	NaN	HRAS,MAPK3	
Costimulation by the CD28 family	-0E00	3.85E-02	NaN	MAP3K8,PPP2CB,PRR5L	
Striated Muscle Contraction	-0E00	2.78E-02	NaN	VIM	
Glutamate binding, activation of AMPA receptors and synaptic plasticity	-0E00	3.12E-02	NaN	AP2A2	
G alpha (q) signalling events	-0E00	4.6E-02	-2.828	EDN1,EDN3,GNA11,GNB2,GNG11,GNG5,GPR4,LPAR6	
G alpha (s) signalling events	-0E00	5.52E-02	-2.828	ADRB2,GNAS,GNB2,GNG11,GNG5,PDE2A,POMC,RAMP2	
Transport of vitamins, nucleosides, and related molecules	-0E00	4.88E-02	NaN	APOD,ARL2BP	
NoRC negatively regulates rRNA expression	-0E00	5.26E-02	NaN	SAP18,SAP30L	
Interleukin-12 family signaling	-0E00	5E-02	NaN	VAMP7	
Interleukin-2 family signaling	-0E00	2.17E-02	NaN	INPP5K	
Interleukin-3, Interleukin-5 and GM-CSF signaling	-0E00	3.64E-02	NaN	INPP5K,UBC	
O-linked glycosylation	-0E00	4.5E-02	-2.236	ADAMTS10,B3GNT2,B4GAT1,C1GALT1C1,ST6GALNAC4	
Miscellaneous transport and binding events	-0E00	3.85E-02	NaN	LRRC8A	
Myogenesis	-0E00	3.45E-02	NaN	TCF3	
Cardiac conduction	-0E00	1.54E-02	NaN	ATP1A2,SRI	
RHO GTPases activate PAKs	-0E00	4.76E-02	NaN	MYL12B	
TNFs bind their physiological receptors	-0E00	3.45E-02	NaN	TNFSF13	
Nonhomologous End-Joining (NHEJ)	-0E00	4.08E-02	NaN	UBE2N,UBE2V2	
Fanconi Anemia Pathway	-0E00	5.26E-02	NaN	RPA3,UBC	
Interleukin-10 signaling	-0E00	2.22E-02	NaN	IL10RB	
Regulation of TP53 Activity through Methylation	-0E00	5.26E-02	NaN	UBC	
Keratinization	-0E00	4.67E-03	NaN	JUP	
Resolution of Abasic Sites (AP sites)	-0E00	5.26E-02	NaN	POLD4,RPA3	
Fatty acyl-CoA biosynthesis	-0E00	3.7E-02	NaN	PPT2	
Nucleosome assembly	-0E00	2.04E-02	NaN	RBBP4	
RET signaling	-0E00	2.44E-02	NaN	DOK4	
Interleukin-20 family signaling	-0E00	3.85E-02	NaN	IL10RB	
GABA synthesis, release, reuptake and degradation	-0E00	5.26E-02	NaN	HSPA8	
RUNX1 regulates megakaryocyte differentiation and platelet function	-0E00	3.45E-02	NaN	DPY30,PRMT1	
Nucleotide catabolism	-0E00	3.33E-02	NaN	NT5C	
Nucleotide salvage	-0E00	4.76E-02	NaN	GMPR2	
Triglyceride metabolism	-0E00	2.94E-02	NaN	PLIN3	
Glycogen metabolism	-0E00	4.17E-02	NaN	UBC	
Transcriptional Regulation by MECP2	-0E00	1.59E-02	NaN	SGK1	
Signaling by NTRK2 (TRKB)	-0E00	4E-02	NaN	HRAS	
Signaling by Erythropoietin	-0E00	4E-02	NaN	HRAS	
Meiotic recombination	-0E00	2.08E-02	NaN	RPA3	
FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes	-0E00	3.33E-02	NaN	POMC	
Transcriptional regulation of granulopoiesis	-0E00	1.96E-02	NaN	CDKN1A	
EGR2 and SOX10-mediated initiation of Schwann cell myelination	-0E00	3.45E-02	NaN	PMP22	
Signaling by CSF1 (M-CSF) in myeloid cells	-0E00	3.23E-02	NaN	UBC	
Heme signaling	-0E00	2.13E-02	NaN	NFE2L2	
GABA receptor activation	-0E00	5E-02	NaN	GNB2,GNG11,GNG5	
Factors involved in megakaryocyte development and platelet production	-0E00	5.49E-02	-2.236	ACTB,CABLES1,CAPZA2,IRF1,RAB5A	
Coagulation System	-0E00	2.86E-02	NaN	PLAT	
Hepatic Cholestasis	-0E00	3.59E-02	-2.121	Calm1 (includes others),JUN,MAPK3,NFKBIA,NR1H2,PRKAG1,TNFSF12,TNFSF13	
Hepatic Fibrosis / Hepatic Stellate Cell Activation	-0E00	4.64E-02	NaN	BAMBI,CCN2,CD40,EDN1,FAS,IFNAR2,IFNGR1,KLF6,PDGFB	
Autism Signaling Pathway	-0E00	5.52E-02	-3.500	AKT1S1,ALDH2,BCKDK,EIF4E,HLA-A,HLA-E,HRAS,MAPK3,PRKAG1,RAP1A,RARG,RASD1,RHEB,RRAS,TCF3,TNFSF12,TNFSF13	
BBSome Signaling Pathway	-0E00	4.91E-02	-2.558	ACKR3,ADGRE5,ADRB2,BBIP1,CCRL2,CCT4,CCT5,CCT8,CXCL12,EZH2,GPR4,IFT20,LPAR6,LZTFL1,MYL11,PHF1,POMC,PRKAG1,RAB5A,RHOA,RNF2,S1PR1,S1PR4,STX3	
HEY1 Signaling Pathway	-0E00	3.73E-02	-0.816	ACVRL1,CDKN1A,PINK1,PRKAB1,PRKAG1,PSENEN	
WNT/SHH Axonal Guidance Signaling Pathway	-0E00	5.37E-02	-0.707	ARF6,ILK,PRKAG1,TCF3,Tcf7,YWHAE,YWHAH,YWHAQ	
PXR/RXR Activation	-0E00	4.62E-02	NaN	ALAS1,GSTM2,PRKAG1	
TR/RXR Activation	-0E00	5.47E-02	-2.646	ENO1,H3-3A/H3-3B,KLF9,NCOA4,PINK1,SLC2A1,UCP2	
Role of BRCA1 in DNA Damage Response	-0E00	3.75E-02	NaN	ACTB,CDKN1A,SMARCB1	
Role of RIG1-like Receptors in Antiviral Innate Immunity	-0E00	4.35E-02	NaN	IRF7,NFKBIA	
Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses	-0E00	2.56E-02	NaN	IRF7,MAPK3,TNFSF12,TNFSF13	
TREM1 Signaling	-0E00	3.9E-02	NaN	CD40,CD83,MAPK3	
Role of NFAT in Regulation of the Immune Response	-0E00	1.64E-02	-2.887	Calm1 (includes others),CSNK1E,FOS,GNA11,GNAS,GNB2,GNG11,GNG5,GSK3A,HLA-A,HRAS,JUN,MAPK3,NFKBIA,RAP1A,RASD1,RRAS	
FcγRIIB Signaling in B Lymphocytes	-0E00	7.53E-03	NaN	HRAS,RAP1A,RASD1,RRAS	
CCR5 Signaling in Macrophages	-0E00	1.8E-02	-2.000	Calm1 (includes others),FAS,FOS,GNA11,GNAS,GNB2,GNG11,GNG5,JUN	
Calcium-induced T Lymphocyte Apoptosis	-0E00	4.35E-03	NaN	Calm1 (includes others),HLA-A	
Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells	-0E00	1.18E-02	NaN	CASP6,CYC1,FAS,HLA-A,HLA-E	
IL-17 Signaling	-0E00	5.35E-02	-3.162	FOS,HRAS,JUN,MAPK3,RAP1A,RASD1,RRAS,TNFSF12,TNFSF13,TRAF5	
Airway Pathology in Chronic Obstructive Pulmonary Disease	-0E00	2.54E-02	NaN	APOD,TNFSF12,TNFSF13	
CTLA4 Signaling in Cytotoxic T Lymphocytes	-0E00	2.8E-02	0.728	AP1M1,AP2A2,ARF1,BCL10,CLTA,FOS,GSK3A,H2-T22,HLA-A,HLA-E,HRAS,JUN,MAPK3,PPP2CB,RAP1A,RASD1,RRAS	
Induction of Apoptosis by HIV1	-0E00	4.62E-02	NaN	CYC1,FAS,NFKBIA	
IL-15 Production	-0E00	1.63E-02	NaN	CLK1,IRF1	
Airway Inflammation in Asthma	-0E00	3.03E-02	NaN	IFNGR1	
T Helper Cell Differentiation	-0E00	8.49E-03	NaN	CD40,HLA-A,IFNGR1,IL10RB	
IL-9 Signaling	-0E00	2.86E-02	NaN	SOCS2	
CD28 Signaling in T Helper Cells	-0E00	1.74E-02	-2.646	ARPC1A,ARPC4,ARPC5L,BCL10,Calm1 (includes others),FOS,HLA-A,JUN,NFKBIA	
IL-15 Signaling	-0E00	1.14E-02	-2.449	AKT1S1,HRAS,MAPK3,RAP1A,RASD1,RRAS	
Dendritic Cell Maturation	-0E00	1.34E-02	-2.828	CD40,CD83,CREB3,HLA-A,HLA-E,MAPK3,NFKBIA,NOTUM	
Neuropathic Pain Signaling in Dorsal Horn Neurons	-0E00	4.95E-02	-2.236	CAMK1,FOS,MAPK3,NOTUM,PRKAG1	
Factors Promoting Cardiogenesis in Vertebrates	-0E00	3.92E-02	-2.236	ACVRL1,CREB3,NOTUM,RHOA,TCF3,Tcf7	
Cardiomyocyte Differentiation via BMP Receptors	-0E00	3.7E-02	NaN	ACVRL1	
ICOS-ICOSL Signaling in T Helper Cells	-0E00	9.86E-03	-2.000	BAD,Calm1 (includes others),CD40,HLA-A,NFKBIA	
Molecular Mechanisms of Cancer	-0E00	5.26E-02	-4.621	ACKR3,ACVRL1,ADGRE5,ADRB2,BAD,CASP6,CCRL2,Cdc42,CDKN1A,CDKN2B,CDKN2D,EDN1,EDN3,FAS,FOS,GNA11,GNAS,GNB2,GNG11,GNG5,GPR4,GSK3A,HES1,HRAS,ID1,IL10RB,JUN,LPAR6,MAPK3,MAX,NFKBIA,PDGFB,PRKAG1,PSENEN,RAP1A,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,S1PR1,S1PR4,TCF3,Tcf7	
Lipid Antigen Presentation by CD1	-0E00	4.82E-03	NaN	AP2A2,ARF6	
Maturity Onset Diabetes of Young (MODY) Signaling	-0E00	3.8E-02	NaN	APOD,APOE,UCP2	
Role of CHK Proteins in Cell Cycle Checkpoint Control	-0E00	3.45E-02	NaN	CDKN1A,PPP2CB	
Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency	-0E00	4.84E-02	-2.000	ACVRL1,HRAS,MAPK3,RAP1A,RASD1,RRAS	
Growth Hormone Signaling	-0E00	4.23E-02	NaN	FOS,MAPK3,SOCS2	
CREB Signaling in Neurons	-0E00	4.78E-02	-4.359	ACKR3,ADGRE5,ADRB2,Calm1 (includes others),CCRL2,CREB3,GNA11,GNAS,GNB2,GNG11,GNG5,GPR4,GTF2B,HRAS,LPAR6,MAPK3,NOTUM,PDGFB,POLR2C,POLR2D,POLR2E,POLR2I,POLR2K,PRKAG1,RAP1A,RASD1,RRAS,S1PR1,S1PR4	
Type I Diabetes Mellitus Signaling	-0E00	1.77E-02	-1.342	CPE,CYC1,FAS,HLA-A,HLA-E,IFNGR1,IRF1,NFKBIA,SOCS2	
Basal Cell Carcinoma Signaling	-0E00	2.78E-02	NaN	TCF3,Tcf7	
Primary Immunodeficiency Signaling	-0E00	4.92E-02	NaN	CD40,RFXAP,TAP2	
Allograft Rejection Signaling	-0E00	1.02E-02	NaN	CD40,FAS,H2-T22,HLA-A,HLA-E	
Autoimmune Thyroid Disease Signaling	-0E00	8.71E-03	NaN	CD40,FAS,HLA-A,HLA-E	
Graft-versus-Host Disease Signaling	-0E00	6.73E-03	NaN	FAS,HLA-A,HLA-E	
Type II Diabetes Mellitus Signaling	-0E00	3.92E-02	0.000	MAPK3,NFKBIA,PRKAB1,PRKAG1,SMPD2,SOCS2	
p70S6K Signaling	-0E00	1.9E-02	-1.134	BAD,HRAS,MAPK3,NOTUM,PPP2CB,RAP1A,RASD1,RRAS,YWHAE,YWHAH,YWHAQ	
Pancreatic Adenocarcinoma Signaling	-0E00	3.97E-02	NaN	BAD,CDKN1A,CDKN1B,CDKN2B,MAPK3	
G Protein Signaling Mediated by Tubby	-0E00	1.07E-02	-2.236	GNA11,GNAS,GNB2,GNG11,GNG5	
Communication between Innate and Adaptive Immune Cells	-0E00	5.36E-03	NaN	CD40,CD83,HLA-A,HLA-E,TNFSF13	
Systemic Lupus Erythematosus Signaling	-0E00	2.16E-02	NaN	CD40,CREM,FOS,HLA-A,HLA-E,HRAS,JUN,LSM3,LSM5,LSM8,MAPK3,PRPF38A,RAP1A,RASD1,RRAS,SF3B4,SNRNP27,SNRNP40,SNRNP48,SNRPB,SNRPB2,Snrpe,ZMAT5	
CDC42 Signaling	-0E00	2.78E-02	-2.887	ARPC1A,ARPC4,ARPC5L,BAIAP2,CDC42SE1,CFL1,CFL2,EXOC7,FOS,H2-T22,HLA-A,HLA-E,JUN,MYL11,MYL12A,MYL12B	
FAK Signaling	-0E00	2.79E-02	-3.528	ACKR3,ADGRE5,ADRB2,ARPC1A,ARPC4,ARPC5L,BAD,CCRL2,EFNA1,FOS,GPR4,GSK3A,HRAS,IL10RB,JUN,LPAR6,MAPK3,RAP1A,RASD1,RHOA,RRAS,S1PR1,S1PR4,SH3GL1,SOCS2,SPARCL1,TCF3,Tcf7,USF1	
Retinoic acid Mediated Apoptosis Signaling	-0E00	3.33E-02	NaN	IRF1,RARG	
Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis	-0E00	5.26E-02	NaN	ACVRL1,ALPL,BAD,Calm1 (includes others),CSNK1E,FOS,JUN,MAPK3,NFKBIA,TCF3,Tcf7,TRAF5	
Phospholipase C Signaling	-0E00	1.7E-02	-3.873	Calm1 (includes others),Cdc42,CREB3,GNAS,GNB2,GNG11,GNG5,HRAS,MAPK3,MYL11,MYL12A,MYL12B,RAP1A,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS	
Altered T Cell and B Cell Signaling in Rheumatoid Arthritis	-0E00	4.26E-03	NaN	CD40,FAS,HLA-A,TNFSF13	
Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis	-0E00	5.41E-02	NaN	Calm1 (includes others),CREB3,CSNK1E,CXCL12,FOS,HRAS,JUN,MAPK3,NFKBIA,NOTUM,PDGFB,RAP1A,RASD1,RHOA,RRAS,TCF3,Tcf7,TRAF5	
Leptin Signaling in Obesity	-0E00	5.26E-02	NaN	MAPK3,NOTUM,POMC,PRKAG1	
B Cell Development	-0E00	4.1E-03	NaN	CD40,HLA-A	
Breast Cancer Regulation by Stathmin1	-0E00	5.22E-02	-2.556	ACKR3,ADGRE5,ADRB2,CAMK1,CCRL2,CDKN1B,CREB3,GNB2,GNG11,GNG5,GPR4,HRAS,JUN,LPAR6,MAPK3,PDGFB,PPP1R11,PPP2CB,PRKAG1,RAP1A,RASD1,RHOA,RRAS,S1PR1,S1PR4,STMN1,TUBA1A,TUBA1B,TUBB,TUBB2A,TUBB4B	
Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes	-0E00	2.6E-02	-2.887	BCL10,Calm1 (includes others),FOS,HRAS,JUN,MAPK3,NFKBIA,PABPC4,RAP1A,RASD1,RRAS,TOB1	
NUR77 Signaling in T Lymphocytes	-0E00	9.75E-03	NaN	Calm1 (includes others),H2-T22,HLA-A,HLA-E,MAPK3	
PKCθ Signaling in T Lymphocytes	-0E00	1.97E-02	-3.162	BCL10,FOS,HLA-A,HRAS,JUN,MAP3K8,MAPK3,NFKBIA,RAP1A,RASD1,RRAS	
Role of PI3K/AKT Signaling in the Pathogenesis of Influenza	-0E00	3.03E-02	NaN	MAPK3,NFKBIA	
Antiproliferative Role of TOB in T Cell Signaling	-0E00	7.04E-03	NaN	CDKN1B,PABPC4,TOB1	
MSP-RON Signaling Pathway	-0E00	3.45E-02	NaN	ACTB,ACTG1	
OX40 Signaling Pathway	-0E00	1.26E-02	NaN	H2-T22,HLA-A,HLA-E,JUN,NFKBIA,TRAF5	
PI3K Signaling in B Lymphocytes	-0E00	2.21E-02	-3.464	ATF3,BCL10,Calm1 (includes others),CD40,FOS,HRAS,JUN,MAPK3,NFKBIA,NOTUM,RAP1A,RASD1,RRAS	
Inhibition of Angiogenesis by TSP1	-0E00	2.94E-02	NaN	JUN	
IL-17A Signaling in Airway Cells	-0E00	2.99E-02	NaN	MAPK3,NFKBIA	
Role of IL-17A in Arthritis	-0E00	3.51E-02	NaN	MAPK3,NFKBIA	
Role of IL-17F in Allergic Inflammatory Airway Diseases	-0E00	4.26E-02	NaN	CREB3,MAPK3	
Role of JAK2 in Hormone-like Cytokine Signaling	-0E00	4.84E-02	NaN	FOS,POMC,SOCS2	
Dopamine-DARPP32 Feedback in cAMP Signaling	-0E00	4.84E-02	-2.121	Calm1 (includes others),CREB3,CREM,CSNK1E,GNAS,NOTUM,PPP1R11,PPP2CB,PRKAG1	
Transcriptional Regulatory Network in Embryonic Stem Cells	-0E00	4.88E-02	-2.121	HRAS,KLF4,MAPK3,RAP1A,RASD1,RRAS,SKIL,TCF3	
nNOS Signaling in Neurons	-0E00	4.26E-02	NaN	Calm1 (includes others),RASD1	
nNOS Signaling in Skeletal Muscle Cells	-0E00	2.08E-02	NaN	Calm1 (includes others)	
GADD45 Signaling	-0E00	3.33E-02	NaN	CDKN1A,GADD45G	
Retinoate Biosynthesis I	-0E00	4.65E-02	NaN	RBP1,RDH14	
Thyroid Hormone Metabolism II (via Conjugation and/or Degradation)	-0E00	4.76E-02	NaN	B3GAT3,B4GAT1	
Nicotine Degradation III	-0E00	3.33E-02	NaN	B3GAT3,B4GAT1	
Heparan Sulfate Biosynthesis (Late Stages)	-0E00	4.82E-02	NaN	ALDH2,HS3ST1,NOTUM,PRDX6	
Pyrimidine Ribonucleotides De Novo Biosynthesis	-0E00	4.65E-02	NaN	CMPK2,PGP	
Androgen Biosynthesis	-0E00	5E-02	NaN	EBP	
Ubiquinol-10 Biosynthesis (Eukaryotic)	-0E00	3.85E-02	NaN	Cyp2d22	
Melatonin Degradation I	-0E00	3.12E-02	NaN	B3GAT3,B4GAT1	
NAD Salvage Pathway II	-0E00	3.7E-02	NaN	NT5C	
Pyrimidine Deoxyribonucleotides De Novo Biosynthesis I	-0E00	4.35E-02	NaN	CMPK2	
Phospholipases	-0E00	4.35E-02	NaN	NOTUM,PNPLA2,PRDX6	
Chondroitin Sulfate Biosynthesis	-0E00	3.28E-02	NaN	B3GAT3,HS3ST1	
Dermatan Sulfate Biosynthesis	-0E00	3.17E-02	NaN	B3GAT3,HS3ST1	
tRNA Charging	-0E00	2.56E-02	NaN	GARS1	
Dermatan Sulfate Biosynthesis (Late Stages)	-0E00	2E-02	NaN	HS3ST1	
Phosphatidylglycerol Biosynthesis II (Non-plastidic)	-0E00	3.33E-02	NaN	PTPMT1	
Nicotine Degradation II	-0E00	4.41E-02	NaN	B3GAT3,B4GAT1,FMO2	
Tryptophan Degradation III (Eukaryotic)	-0E00	4.35E-02	NaN	HADHB	
Pyrimidine Ribonucleotides Interconversion	-0E00	5E-02	NaN	CMPK2,PGP	
Histamine Degradation	-0E00	4.76E-02	NaN	ALDH2	
Chondroitin Sulfate Biosynthesis (Late Stages)	-0E00	1.89E-02	NaN	HS3ST1	
Superpathway of Melatonin Degradation	-0E00	4.35E-02	NaN	B3GAT3,B4GAT1,SMOX	
Histidine Degradation VI	-0E00	4.35E-02	NaN	Cyp2d22	
Pregnenolone Biosynthesis	-0E00	4.55E-02	NaN	Cyp2d22	
Acetone Degradation I (to Methylglyoxal)	-0E00	2.38E-02	NaN	DHRS7	
Fatty Acid α-oxidation	-0E00	4.76E-02	NaN	ALDH2	
Oxidative Ethanol Degradation III	-0E00	3.57E-02	NaN	ALDH2,Cyp2d22	
Ethanol Degradation IV	-0E00	4E-02	NaN	ALDH2	
Antioxidant Action of Vitamin C	-0E00	5.26E-02	NaN	MAPK3,NFKBIA,NOTUM,PNPLA2,PRDX6,SLC2A1	
Agranulocyte Adhesion and Diapedesis	-0E00	2.86E-02	NaN	ACKR3,ACTB,ACTG1,CLDN5,CXCL12,ICAM2	
Granulocyte Adhesion and Diapedesis	-0E00	2.12E-02	NaN	ACKR3,CLDN5,CXCL12,ICAM2	
Regulation of the Epithelial-Mesenchymal Transition Pathway	-0E00	5.13E-02	NaN	HRAS,ID2,MAPK3,PSENEN,RAP1A,RASD1,RHOA,RRAS,TCF3,Tcf7	
Role of p14/p19ARF in Tumor Suppression	-0E00	3.33E-02	NaN	UBTF	
Sperm Motility	-0E00	4.67E-02	-2.236	Calm1 (includes others),CLK1,GNA11,GNAS,GNB2,GNG11,GNG5,NOTUM,PDE2A,PNPLA2,PRDX6,PRKAG1	
TEC Kinase Signaling	-0E00	2.6E-02	-3.000	ACTB,ACTG1,Cdc42,FAS,FOS,GNA11,GNAS,GNB2,GNG11,GNG5,RHOA,RHOB,RHOC,RHOG,TNFSF12	
BER (Base Excision Repair) Pathway	-0E00	4.55E-02	NaN	ARL6IP5,MAPK3	
WNT/Ca+ pathway	-0E00	3.03E-02	NaN	CREB3,NOTUM	
SAPK/JNK Signaling	-0E00	1.79E-02	-2.646	GNB2,GNG11,GNG5,HNRNPK,HRAS,JUN,RAP1A,RASD1,RRAS	
Nitric Oxide Signaling in the Cardiovascular System	-0E00	3.33E-02	-1.000	Calm1 (includes others),MAPK3,PDE2A,PRKAG1	
FGF Signaling	-0E00	3.49E-02	NaN	CREB3,HRAS,MAPK3	
IL-4 Signaling	-0E00	1.56E-02	-2.333	AKT1S1,CREB3,FAS,HRAS,MAPK3,PRR5L,RAP1A,RASD1,RRAS	
B Cell Receptor Signaling	-0E00	2.68E-02	-2.324	BAD,BCL10,Calm1 (includes others),CFL1,CFL2,CREB3,GSK3A,HRAS,INPP5K,JUN,MAP3K8,MAPK3,NFKBIA,RAP1A,RASD1,RRAS,TCF3	
Phototransduction Pathway	-0E00	1.85E-02	NaN	PRKAG1	
Sonic Hedgehog Signaling	-0E00	3.23E-02	NaN	PRKAG1	
NF-κB Signaling	-0E00	2.1E-02	-2.714	BCL10,CD40,CSNK2B,HRAS,MAP3K8,NFKBIA,RAP1A,RASD1,RRAS,TRAF5,UBE2N,UBE2V1	
T Cell Receptor Signaling	-0E00	2.92E-02	-2.668	AKT1S1,BCL10,Calm1 (includes others),CDKN1B,FOS,GSK3A,H2-T22,HLA-A,HLA-E,HRAS,JUN,MAPK3,NFKBIA,RAP1A,RASD1,RRAS,TCF3,Tcf7	
G-Protein Coupled Receptor Signaling	-0E00	4.84E-02	-3.773	ACKR3,ADGRE5,ADRB2,Calm1 (includes others),CCRL2,CREB3,DUSP1,FOS,GDE1,GNA11,GNAS,GNB2,GNG11,GNG5,GPR4,HCN2,HRAS,JUN,LPAR6,MAP3K8,MAPK3,MYL11,MYL12A,MYL12B,NFKBIA,PDE2A,PRKAG1,RAP1A,RASD1,RGS12,RRAS,S1PR1,S1PR4,SMPDL3A	
GPCR-Mediated Nutrient Sensing in Enteroendocrine Cells	-0E00	5.08E-02	-2.449	GNA11,GNAS,GNG11,GNG5,NOTUM,PRKAG1	
Gustation Pathway	-0E00	1.98E-02	NaN	LPAR6,LRRC8A,NOTUM,PRKAG1	
Phagosome Formation	-0E00	3.74E-02	-4.200	ACKR3,ADGRE5,ADRB2,AP1M1,ARF6,ARPC1A,ARPC4,ARPC5L,BCL10,CCRL2,CFL1,CFL2,GPR4,HRAS,LPAR6,MAPK3,MYL12A,MYL12B,PNPLA2,PRDX6,RAP1A,RASD1,RHOA,RRAS,S1PR1,S1PR4	
Th1 and Th2 Activation Pathway	-0E00	4.65E-02	NaN	CD40,HLA-A,IFNGR1,IL10RB,IRF1,JUN,PSENEN,S1PR1	
Th1 Pathway	-0E00	4.92E-02	-2.449	CD40,HLA-A,IFNGR1,IL10RB,IRF1,PSENEN	
Th2 Pathway	-0E00	3.65E-02	-1.000	CD40,HLA-A,JUN,PSENEN,S1PR1	
Osteoarthritis Pathway	-0E00	4.66E-02	-1.265	ACVRL1,ALPL,CASP6,CREB3,HES1,HTRA1,PRKAB1,PRKAG1,SLC39A8,TCF3,Tcf7	
GP6 Signaling Pathway	-0E00	3.15E-02	-1.000	Calm1 (includes others),GSK3A,RASGRP2,RHOG	
Neuroinflammation Signaling Pathway	-0E00	4.1E-02	-3.464	CD40,CREB3,CXCL12,FAS,FOS,HLA-A,HLA-E,IFNGR1,IRF7,JUN,MAPK3,NFE2L2,PSENEN	
SPINK1 Pancreatic Cancer Pathway	-0E00	1.67E-02	NaN	CPE	
Endocannabinoid Neuronal Synapse Pathway	-0E00	5.37E-02	-1.134	GNA11,GNB2,GNG11,GNG5,MAPK3,NDUFS2,NOTUM,PRKAG1	
Apelin Pancreas Signaling Pathway	-0E00	4.35E-02	NaN	PRKAB1,PRKAG1	
Cardiac Hypertrophy Signaling (Enhanced)	-0E00	5.35E-02	-4.600	ADRB2,Calm1 (includes others),EDN1,EIF2B4,EIF4E,GDE1,GNA11,GNAS,GNB2,GNG11,GNG5,GSK3A,HRAS,HSPB1,IL10RB,JUN,MAP3K8,MAPK3,MKNK2,NOTUM,PDE2A,PRKAG1,RAP1A,RASD1,RHOA,RRAS,SMPDL3A,TNFSF12,TNFSF13	
T Cell Exhaustion Signaling Pathway	-0E00	2.12E-02	-1.000	FOS,HLA-A,HLA-E,HRAS,IFNAR2,IL10RB,JUN,MAPK3,PPP2CB,RAP1A,RASD1,RRAS	
IL-23 Signaling Pathway	-0E00	2.17E-02	NaN	NFKBIA	
Systemic Lupus Erythematosus in T Cell Signaling Pathway	-0E00	3.42E-02	-0.853	AKT1S1,CASP6,Cdc42,CREB3,CREM,FAS,FOS,H2-T22,HLA-A,HLA-E,HRAS,JUN,MAPK3,PPP2CB,RAB4A,RAP1A,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS	
Systemic Lupus Erythematosus in B Cell Signaling Pathway	-0E00	3.04E-02	-3.838	BAD,BCL10,Calm1 (includes others),CD40,FOS,HRAS,IFIT3,IFNAR2,IFNGR1,INPP5K,IRF7,ISG15,JUN,MAPK3,MCL1,RAP1A,RASD1,RASGRP2,RRAS,TNFSF12,TNFSF13,TRAF5	
White Adipose Tissue Browning Pathway	-0E00	5.07E-02	-2.646	CREB3,GNAS,LDHA,PRDM16,PRKAB1,PRKAG1,RARG	
Xenobiotic Metabolism CAR Signaling Pathway	-0E00	4.64E-02	-2.333	ALDH2,FMO2,GSTK1,GSTM2,GSTM5,GSTT2/GSTT2B,HS3ST1,MAPK3,PPP2CB	
Xenobiotic Metabolism PXR Signaling Pathway	-0E00	5.13E-02	-3.162	ALDH2,ESD,GSTK1,GSTM2,GSTM5,GSTT2/GSTT2B,HS3ST1,PPP1R11,PRKAG1,SMOX	
Regulation of the Epithelial Mesenchymal Transition in Development Pathway	-0E00	3.45E-02	NaN	PSENEN,TCF3,Tcf7	
Calcium Signaling	-0E00	2.73E-02	-2.449	Calm1 (includes others),CAMK1,CREB3,MAPK3,PRKAG1,RAP1A	
